Ansbert Gadicke - Insider Trading Tracker

अवलो थेरेप्यूटिक्स, इंक.

US ˙ NasdaqCM

परिचय

यह पृष्ठ Ansbert Gadicke के ज्ञात इनसाइडर व्यापार इतिहास का व्यापक विश्लेषण प्रदान करता है। इनसाइडर किसी कंपनी के अधिकारी, निदेशक या महत्वपूर्ण निवेशक होते हैं। इनसाइडर के लिए विशिष्ट, गैर-सार्वजनिक जानकारी के आधार पर अपनी कंपनियों में व्यापार करना गैरकानूनी है। इसका मतलब यह नहीं है कि उनके लिए अपनी कंपनियों में कोई भी व्यापार करना गैरकानूनी है। हालाँकि, उन्हें फॉर्म 4 के माध्यम से SEC को सभी ट्रेड्स की रिपोर्ट करनी होगी। इन प्रतिबंधों के बावजूद, अकादमिक शोध से पता चलता है कि इनसाइडर - सामान्य तौर पर - अपनी कंपनियों में बाजार से बेहतर प्रदर्शन करते हैं।

औसत व्यापार लाभप्रदता

औसत ट्रेड लाभप्रदता पिछले तीन वर्षों में इनसाइडर द्वारा की गई सभी खुले बाजार खरीद का औसत रिटर्न है। इसकी गणना करने के लिए, हम 10b5-1 ट्रेडिंग योजना के हिस्से के रूप में चिह्नित सभी ट्रेडों को छोड़कर, इनसाइडर द्वारा की गई प्रत्येक खुले बाजार, अनियोजित खरीदारी की जांच करते हैं। फिर हम 3, 6 और 12 महीनों में उन ट्रेडों के औसत प्रदर्शन की गणना करते हैं, प्रत्येक ट्रेड के लिए अंतिम प्रदर्शन मीट्रिक तैयार करने के लिए उनमें से प्रत्येक अवधि का औसत निकालते हैं। अंत में, हम इनसाइडर के लिए प्रदर्शन मीट्रिक की गणना करने के लिए सभी प्रदर्शन मीट्रिक का औसत निकालते हैं। इस सूची में केवल उन इनसाइडर को शामिल किया गया है जिन्होंने पिछले दो वर्षों में कम से कम तीन ट्रेड किए हैं।

यदि इस इनसाइडर ट्रेड की लाभप्रदता "N/A" है, तो इनसाइडर ने या तो पिछले तीन वर्षों में कोई खुले बाजार में खरीदारी नहीं की है, या उनके द्वारा किए गए व्यापार एक विश्वसनीय प्रदर्शन मीट्रिक की गणना करने के लिए बहुत हाल के हैं।

अपडेट फ्रीक्वेंसी: दैनिक

सर्वाधिक लाभदायक इनसाइडर व्यापारियों की सूची देखें।

उच्चतम रैंकिंग वाले इनसाइडर देखें

रिपोर्ट की गई इनसाइडर स्थिति वाली कंपनियाँ

SEC फाइलिंग से संकेत मिलता है कि Ansbert Gadicke ने निम्नलिखित कंपनियों में होल्डिंग्स या ट्रेड्स की सूचना दी है:

प्रतिभूति	टाइटल	नवीनतम रिपोर्ट की गई होल्डिंग्स
US:ITOS / iTeos Therapeutics, Inc.		3,452,797
US:HOWL / Werewolf Therapeutics, Inc.	10% Owner	6,718,670
US:TRDA / Entrada Therapeutics, Inc.	10% Owner	4,381,062
US:TCRR / Tcr2 Therapeutics Inc	Director, 10% Owner	0
US:CGEM / Cullinan Therapeutics, Inc.	10% Owner	595,489
US:ALVR / AlloVir, Inc.	Director, 10% Owner	16,674,766
US:RPTX / Repare Therapeutics Inc.	10% Owner	3,882,485
US:HARP / Harpoon Therapeutics, Inc.	10% Owner	6,328,095
US:ONCR / Oncorus, Inc.	10% Owner	0
	10% Owner	0
US:RYTM / Rhythm Pharmaceuticals, Inc.	10% Owner	0
US:RDUS / Radius Recycling, Inc.	Director	27,500
	Director	10,000
US:SNDX / Syndax Pharmaceuticals, Inc.	10% Owner	0
US:AVTX / Avalo Therapeutics, Inc.	10% Owner	0
US:TRIV / TriVascular Technologies, Inc.	10% Owner	37,369
US:PETX / Aratana Therapeutics, Inc.	10% Owner	2,751,048
US:EPZM / Epizyme Inc	10% Owner	2,413,819
US:CNAT / Conatus Pharmaceuticals Inc.	10% Owner	32,220
US:PCRX / Pacira BioSciences, Inc.		2,790,479
US:KBIO / KaloBios Pharmaceuticals, Inc.	10% Owner	0
US:SOMX / Somaxon Pharmaceuticals, Inc.	10% Owner	1,275,886
US:VSTM / Verastem, Inc.	Director	12,500

चार्ट को कैसे समझे

निम्नलिखित चार्ट Ansbert Gadicke द्वारा किए गए प्रत्येक खुले-बाज़ार, गैर-योजनाबद्ध व्यापार के बाद प्रतिभूतियों के स्टॉक प्रदर्शन को दर्शाते हैं। गैर-योजनाबद्ध व्यापार वे व्यापार हैं जो 10b5-1 ट्रेडिंग योजना के हिस्से के रूप में नहीं किए गए थे। स्टॉक प्रदर्शन को शेयर मूल्य में संचयी प्रतिशत परिवर्तन के रूप में चार्ट किया गया है। उदाहरण के लिए, यदि कोई इनसाइडर व्यापार 1 जनवरी, 2019 को किया गया था, तो चार्ट आज तक प्रतिभूति में दैनिक प्रतिशत परिवर्तन दिखाएगा। यदि इस दौरान शेयर की कीमत $10 से $15 तक जाती है, तो शेयर की कीमत में संचयी प्रतिशत परिवर्तन 50% होगा। $10 से $20 तक की कीमत में परिवर्तन 100% होगा, और $10 से $5 की कीमत में परिवर्तन -50% होगा।

अंततः, हम यह निर्धारित करने का प्रयास कर रहे हैं कि इनसाइडर के व्यापार शेयर की कीमत में अतिरिक्त रिटर्न (सकारात्मक या नकारात्मक) से कितनी निकटता से संबंधित हैं, यह देखने के लिए कि क्या इनसाइडर, इनसाइडर जानकारी से लाभ के लिए अपने व्यापार का समय निर्धारित कर रहे हैं। उस स्थिति पर विचार करें जहां कोई इनसाइडर ऐसा कर रहा था। इस स्थिति में, हम या तो (a) खरीदारी के बाद सकारात्मक रिटर्न, या (a) बिक्री के बाद नकारात्मक रिटर्न की उम्मीद करेंगे। (a) के मामले में, खरीद चार्ट ऊपर की ओर झुके हुए वक्रों की एक श्रृंखला दिखाएगा, जो प्रत्येक खरीद लेनदेन के बाद सकारात्मक रिटर्न का संकेत देगा। (a) के मामले में, बिक्री चार्ट नीचे की ओर झुके हुए वक्रों की एक श्रृंखला दिखाएगा, जो प्रत्येक बिक्री लेनदेन के बाद नकारात्मक रिटर्न का संकेत देगा।

हालाँकि, केवल यह निष्कर्ष निकालने के लिए पर्याप्त नहीं है। यदि, उदाहरण के लिए, कंपनी का शेयर मूल्य कई वर्षों से गैर-चक्रीय चढ़ाई में था, तो हम उम्मीद करेंगे कि खरीद के बाद के सभी प्लॉट ऊपर की ओर झुके हुए होंगे। इसी तरह, कई वर्षों में गैर-चक्रीय गिरावट के परिणामस्वरूप व्यापार के बाद के प्लॉट नीचे की ओर झुकेंगे। इनमें से कोई भी चार्ट इनसाइडर व्यापार गतिविधि का सुझाव नहीं देगा।

सबसे मजबूत संकेतक वह स्थिति होगी जहां शेयर की कीमत बेहद चक्रीय थी, और खरीद चार्ट में सकारात्मक संकेत और बिक्री चार्ट पर नकारात्मक प्लॉट दोनों थे। यह स्थिति एक इनसाइडर के लिए अत्यधिक संकेत देने वाली होगी जो अपने वित्तीय लाभ के लिए ट्रेड्स का समय निर्धारित कर रहा था।

इनसाइडर खरीदारी AVTX / Avalo Therapeutics, Inc. - अल्पकालिक लाभ विश्लेषण

इस अनुभाग में, हम AVTX / Avalo Therapeutics, Inc. में की गई प्रत्येक अनियोजित, खुले बाज़ार की इनसाइडर खरीदारी की लाभप्रदता का विश्लेषण करते हैं। यह विश्लेषण यह समझने में मदद करता है कि क्या इनसाइडर लगातार असामान्य रिटर्न उत्पन्न करता है, और यह अनुसरण करने लायक है। यह विश्लेषण प्रत्येक व्यापार के बाद एक वर्ष के लिए है, और परिणाम सैद्धांतिक हैं।

निम्न तालिका सबसे हालिया खुले बाज़ार की खरीदारी को दर्शाती है जो स्वचालित ट्रेडिंग योजना का हिस्सा नहीं थी।

व्यापार की तिथि	टिकर	इनसाइडर	रिपोर्ट किए गए शेयर	रिपोर्ट की गई कीमत	समायोजित शेयर	समायोजित कीमत	मूल लागत	दिन अधिकतम	मूल्य अधिकतम	अधिकतम लाभ ($)	अधिकतम रिटर्न (%)
इस इनसाइडर और प्रतिभूति संयोजन के लिए कोई ज्ञात अनियोजित खुले बाज़ार व्यापार नहीं हैं

समायोजित कीमत विभाजित-समायोजित कीमत है। समायोजित शेयर विभाजित-समायोजित शेयर हैं।

AVTX / Avalo Therapeutics, Inc. Insider Trades

इनसाइडर बिक्री AVTX / Avalo Therapeutics, Inc. - अल्पकालिक हानि विश्लेषण

इस अनुभाग में, हम AVTX / Avalo Therapeutics, Inc. में की गई प्रत्येक अनियोजित, खुले बाज़ार की इनसाइडर बिक्री के अल्पकालिक नुकसान से बचने का विश्लेषण करते हैं। हानि से बचने का एक सुसंगत पैटर्न यह सुझाव दे सकता है कि भविष्य में बिक्री लेनदेन कीमत में गिरावट की भविष्यवाणी कर सकते हैं। यह विश्लेषण प्रत्येक व्यापार के बाद एक वर्ष के लिए है, और परिणाम सैद्धांतिक हैं।

निम्न तालिका सबसे हालिया खुले बाज़ार की बिक्री को दर्शाती है जो स्वचालित ट्रेडिंग योजना का हिस्सा नहीं थी।

व्यापार की तिथि	टिकर	इनसाइडर	रिपोर्ट किए गए शेयर	रिपोर्ट की गई कीमत	समायोजित शेयर	समायोजित कीमत	मूल लागत	दिन न्यूनतम	मूल्य न्यूनतम	अधिकतम हानि बचाया ($)	अधिकतम हानि बचाया (%)
इस इनसाइडर और प्रतिभूति संयोजन के लिए कोई ज्ञात अनियोजित खुले बाज़ार व्यापार नहीं हैं

इनसाइडर खरीदारी CGEM / Cullinan Therapeutics, Inc. - अल्पकालिक लाभ विश्लेषण

व्यापार की तिथि	टिकर	इनसाइडर	रिपोर्ट किए गए शेयर	रिपोर्ट की गई कीमत	समायोजित शेयर	समायोजित कीमत	मूल लागत	दिन अधिकतम	मूल्य अधिकतम	अधिकतम लाभ ($)	अधिकतम रिटर्न (%)
इस इनसाइडर और प्रतिभूति संयोजन के लिए कोई ज्ञात अनियोजित खुले बाज़ार व्यापार नहीं हैं

CGEM / Cullinan Therapeutics, Inc. Insider Trades

इनसाइडर बिक्री CGEM / Cullinan Therapeutics, Inc. - अल्पकालिक हानि विश्लेषण

व्यापार की तिथि	टिकर	इनसाइडर	रिपोर्ट किए गए शेयर	रिपोर्ट की गई कीमत	समायोजित शेयर	समायोजित कीमत	मूल लागत	दिन न्यूनतम	मूल्य न्यूनतम	अधिकतम हानि बचाया ($)	अधिकतम हानि बचाया (%)
2021-09-01	CGEM	GADICKE ANSBERT	790	29.4700	790	29.4700	23,281	252	7.3100	-17,506	-75.19

इनसाइडर खरीदारी HOWL / Werewolf Therapeutics, Inc. - अल्पकालिक लाभ विश्लेषण

व्यापार की तिथि	टिकर	इनसाइडर	रिपोर्ट किए गए शेयर	रिपोर्ट की गई कीमत	समायोजित शेयर	समायोजित कीमत	मूल लागत	दिन अधिकतम	मूल्य अधिकतम	अधिकतम लाभ ($)	अधिकतम रिटर्न (%)
2021-05-04	HOWL	GADICKE ANSBERT	245,000	16.0000	245,000	16.0000	3,920,000	59	20.3100	1,055,950	26.94

HOWL / Werewolf Therapeutics, Inc. Insider Trades

इनसाइडर बिक्री HOWL / Werewolf Therapeutics, Inc. - अल्पकालिक हानि विश्लेषण

व्यापार की तिथि	टिकर	इनसाइडर	रिपोर्ट किए गए शेयर	रिपोर्ट की गई कीमत	समायोजित शेयर	समायोजित कीमत	मूल लागत	दिन न्यूनतम	मूल्य न्यूनतम	अधिकतम हानि बचाया ($)	अधिकतम हानि बचाया (%)
2025-03-27	HOWL	GADICKE ANSBERT	4,386	1.0500	4,386	1.0500	4,605	11	0.6300	-1,842	-40.00

इनसाइडर खरीदारी HSTOQ / Histogen Inc. - अल्पकालिक लाभ विश्लेषण

व्यापार की तिथि	टिकर	इनसाइडर	रिपोर्ट किए गए शेयर	रिपोर्ट की गई कीमत	समायोजित शेयर	समायोजित कीमत	मूल लागत	दिन अधिकतम	मूल्य अधिकतम	अधिकतम लाभ ($)	अधिकतम रिटर्न (%)
इस इनसाइडर और प्रतिभूति संयोजन के लिए कोई ज्ञात अनियोजित खुले बाज़ार व्यापार नहीं हैं

इनसाइडर बिक्री HSTOQ / Histogen Inc. - अल्पकालिक हानि विश्लेषण

व्यापार की तिथि	टिकर	इनसाइडर	रिपोर्ट किए गए शेयर	रिपोर्ट की गई कीमत	समायोजित शेयर	समायोजित कीमत	मूल लागत	दिन न्यूनतम	मूल्य न्यूनतम	अधिकतम हानि बचाया ($)	अधिकतम हानि बचाया (%)
इस इनसाइडर और प्रतिभूति संयोजन के लिए कोई ज्ञात अनियोजित खुले बाज़ार व्यापार नहीं हैं

इनसाइडर खरीदारी PCRX / Pacira BioSciences, Inc. - अल्पकालिक लाभ विश्लेषण

व्यापार की तिथि	टिकर	इनसाइडर	रिपोर्ट किए गए शेयर	रिपोर्ट की गई कीमत	समायोजित शेयर	समायोजित कीमत	मूल लागत	दिन अधिकतम	मूल्य अधिकतम	अधिकतम लाभ ($)	अधिकतम रिटर्न (%)
इस इनसाइडर और प्रतिभूति संयोजन के लिए कोई ज्ञात अनियोजित खुले बाज़ार व्यापार नहीं हैं

PCRX / Pacira BioSciences, Inc. Insider Trades

इनसाइडर बिक्री PCRX / Pacira BioSciences, Inc. - अल्पकालिक हानि विश्लेषण

व्यापार की तिथि	टिकर	इनसाइडर	रिपोर्ट किए गए शेयर	रिपोर्ट की गई कीमत	समायोजित शेयर	समायोजित कीमत	मूल लागत	दिन न्यूनतम	मूल्य न्यूनतम	अधिकतम हानि बचाया ($)	अधिकतम हानि बचाया (%)
इस इनसाइडर और प्रतिभूति संयोजन के लिए कोई ज्ञात अनियोजित खुले बाज़ार व्यापार नहीं हैं

इनसाइडर खरीदारी RPTX / Repare Therapeutics Inc. - अल्पकालिक लाभ विश्लेषण

व्यापार की तिथि	टिकर	इनसाइडर	रिपोर्ट किए गए शेयर	रिपोर्ट की गई कीमत	समायोजित शेयर	समायोजित कीमत	मूल लागत	दिन अधिकतम	मूल्य अधिकतम	अधिकतम लाभ ($)	अधिकतम रिटर्न (%)
2020-06-23	RPTX	GADICKE ANSBERT	500,000	20.0000	500,000	20.0000	10,000,000	198	44.46	12,230,000	122.30

RPTX / Repare Therapeutics Inc. Insider Trades

इनसाइडर बिक्री RPTX / Repare Therapeutics Inc. - अल्पकालिक हानि विश्लेषण

व्यापार की तिथि	टिकर	इनसाइडर	रिपोर्ट किए गए शेयर	रिपोर्ट की गई कीमत	समायोजित शेयर	समायोजित कीमत	मूल लागत	दिन न्यूनतम	मूल्य न्यूनतम	अधिकतम हानि बचाया ($)	अधिकतम हानि बचाया (%)
2021-03-12	RPTX	GADICKE ANSBERT	695,000	28.1800	695,000	28.1800	19,585,100	364	12.2100	-11,099,150	-56.67

इनसाइडर खरीदारी RYTM / Rhythm Pharmaceuticals, Inc. - अल्पकालिक लाभ विश्लेषण

व्यापार की तिथि	टिकर	इनसाइडर	रिपोर्ट किए गए शेयर	रिपोर्ट की गई कीमत	समायोजित शेयर	समायोजित कीमत	मूल लागत	दिन अधिकतम	मूल्य अधिकतम	अधिकतम लाभ ($)	अधिकतम रिटर्न (%)
2017-10-10	RYTM	MPM BIOVENTURES V, L.P.	100,000	17.0000	100,000	17.0000	1,700,000	268	35.85	1,885,000	110.88

RYTM / Rhythm Pharmaceuticals, Inc. Insider Trades

इनसाइडर बिक्री RYTM / Rhythm Pharmaceuticals, Inc. - अल्पकालिक हानि विश्लेषण

व्यापार की तिथि	टिकर	इनसाइडर	रिपोर्ट किए गए शेयर	रिपोर्ट की गई कीमत	समायोजित शेयर	समायोजित कीमत	मूल लागत	दिन न्यूनतम	मूल्य न्यूनतम	अधिकतम हानि बचाया ($)	अधिकतम हानि बचाया (%)
इस इनसाइडर और प्रतिभूति संयोजन के लिए कोई ज्ञात अनियोजित खुले बाज़ार व्यापार नहीं हैं

इनसाइडर खरीदारी SNDX / Syndax Pharmaceuticals, Inc. - अल्पकालिक लाभ विश्लेषण

व्यापार की तिथि	टिकर	इनसाइडर	रिपोर्ट किए गए शेयर	रिपोर्ट की गई कीमत	समायोजित शेयर	समायोजित कीमत	मूल लागत	दिन अधिकतम	मूल्य अधिकतम	अधिकतम लाभ ($)	अधिकतम रिटर्न (%)
इस इनसाइडर और प्रतिभूति संयोजन के लिए कोई ज्ञात अनियोजित खुले बाज़ार व्यापार नहीं हैं

SNDX / Syndax Pharmaceuticals, Inc. Insider Trades

इनसाइडर बिक्री SNDX / Syndax Pharmaceuticals, Inc. - अल्पकालिक हानि विश्लेषण

व्यापार की तिथि	टिकर	इनसाइडर	रिपोर्ट किए गए शेयर	रिपोर्ट की गई कीमत	समायोजित शेयर	समायोजित कीमत	मूल लागत	दिन न्यूनतम	मूल्य न्यूनतम	अधिकतम हानि बचाया ($)	अधिकतम हानि बचाया (%)
इस इनसाइडर और प्रतिभूति संयोजन के लिए कोई ज्ञात अनियोजित खुले बाज़ार व्यापार नहीं हैं

इनसाइडर खरीदारी TRDA / Entrada Therapeutics, Inc. - अल्पकालिक लाभ विश्लेषण

व्यापार की तिथि	टिकर	इनसाइडर	रिपोर्ट किए गए शेयर	रिपोर्ट की गई कीमत	समायोजित शेयर	समायोजित कीमत	मूल लागत	दिन अधिकतम	मूल्य अधिकतम	अधिकतम लाभ ($)	अधिकतम रिटर्न (%)
2021-11-02	TRDA	MPM BioVentures 2014, L.P.	100,000	20.0000	100,000	20.0000	2,000,000	15	35	1,500,000	75.00

TRDA / Entrada Therapeutics, Inc. Insider Trades

इनसाइडर बिक्री TRDA / Entrada Therapeutics, Inc. - अल्पकालिक हानि विश्लेषण

व्यापार की तिथि	टिकर	इनसाइडर	रिपोर्ट किए गए शेयर	रिपोर्ट की गई कीमत	समायोजित शेयर	समायोजित कीमत	मूल लागत	दिन न्यूनतम	मूल्य न्यूनतम	अधिकतम हानि बचाया ($)	अधिकतम हानि बचाया (%)
2024-12-11	TRDA	MPM BioVentures 2014, L.P.	21,787	20.2300	21,787	20.2300	440,751	243	5.0200	-331,380	-75.19
2024-12-10	TRDA	MPM BioVentures 2014, L.P.	22,935	20.7700	22,935	20.7700	476,360

इनसाइडर खरीदारी VSTM / Verastem, Inc. - अल्पकालिक लाभ विश्लेषण

व्यापार की तिथि	टिकर	इनसाइडर	रिपोर्ट किए गए शेयर	रिपोर्ट की गई कीमत	समायोजित शेयर	समायोजित कीमत	मूल लागत	दिन अधिकतम	मूल्य अधिकतम	अधिकतम लाभ ($)	अधिकतम रिटर्न (%)
2012-02-01	VSTM	GADICKE ANSBERT	96,260	10.0000	8,022	120.0000	962,600	43	1729.44	12,909,238	1,341.08
2012-02-01	VSTM	GADICKE ANSBERT	3,740	10.0000	312	120.0000	37,400

इनसाइडर बिक्री VSTM / Verastem, Inc. - अल्पकालिक हानि विश्लेषण

व्यापार की तिथि	टिकर	इनसाइडर	रिपोर्ट किए गए शेयर	रिपोर्ट की गई कीमत	समायोजित शेयर	समायोजित कीमत	मूल लागत	दिन न्यूनतम	मूल्य न्यूनतम	अधिकतम हानि बचाया ($)	अधिकतम हानि बचाया (%)
इस इनसाइडर और प्रतिभूति संयोजन के लिए कोई ज्ञात अनियोजित खुले बाज़ार व्यापार नहीं हैं

इनसाइडर व्यापार इतिहास

यह तालिका सिक्योरिटीज एक्सचेंज कमीशन (SEC) को बताए अनुसार Ansbert Gadicke द्वारा किए गए इनसाइडर व्यापारों की पूरी सूची दिखाती है।

फ़ाइल तिथि	ट्रांजेक्शन तिथि	फॉर्म	टिकर	प्रतिभूति	कोड	10b5-1	शेयर	शेष शेयर	प्रतिशत परिवर्तन	शेयर कीमत	ट्रांजेक्शन वैल्यू	शेष मूल्य
2025-05-15	2025-05-13	4	ITOS	iTeos Therapeutics, Inc. Common Stock	S - Sale		-1,031,931	3,452,797	-23.01	8.06	-8,317,364	27,829,544
2025-04-30	2025-03-27	4	HOWL	Werewolf Therapeutics, Inc. Common Stock	S - Sale		-4,386	6,718,670	-0.07	1.05	-4,605	7,054,604
2025-04-30	2025-03-27	4	HOWL	Werewolf Therapeutics, Inc. Common Stock	X - Other		50,873	6,723,056	0.76	0.09	4,579	605,075
2024-12-12	2024-12-11	4	TRDA	Entrada Therapeutics, Inc. Common Stock	S - Sale		-21,787	4,381,062	-0.49	20.23	-440,751	88,628,884
2024-12-12	2024-12-10	4	TRDA	Entrada Therapeutics, Inc. Common Stock	S - Sale		-22,935	4,402,849	-0.52	20.77	-476,360	91,447,174
2023-06-05	2023-06-01	4	TCRR	TCR2 THERAPEUTICS INC. Common Stock	J - Other		-3,370,982	0	-100.00
2023-06-05	2023-06-01	4	TCRR	TCR2 THERAPEUTICS INC. Common Stock	J - Other		-3,854,963	0	-100.00
2023-06-05	2023-06-01	4	TCRR	TCR2 THERAPEUTICS INC. Common Stock	J - Other		-304,001	0	-100.00
2023-05-24	2023-05-22	4	TCRR	TCR2 THERAPEUTICS INC. Common Stock	S - Sale		-70,170	304,001	-18.75	1.88	-131,920	571,522
2023-05-24	2023-05-22	4	TCRR	TCR2 THERAPEUTICS INC. Common Stock	X - Other		178,269	374,171	91.00	0.74	131,919	276,887
2023-02-10	2021-12-21	5	CGEM	Cullinan Oncology, Inc. Common Stock	M - Exercise		350,938	595,489	143.50	4.30	1,509,033	2,560,603
2022-08-01	2022-07-28	4	ALVR	Allovir, Inc. Common Stock	A - Award		3,253,796	16,674,766	24.24	4.61	15,000,000	76,870,671
2022-05-19	2022-05-17	4	ALVR	Allovir, Inc. Stock Option (Right to Buy)	A - Award		27,500	27,500
2022-03-25	2021-09-16	4	CGEM	Cullinan Oncology, Inc. Stock Option (Right to Buy)	A - Award		7,800	7,800
2022-01-06	2022-01-05	4	ITOS	iTeos Therapeutics, Inc. Common Stock	S - Sale		-30,347	4,484,728	-0.67	42.03	-1,275,484	188,493,118
2022-01-06	2022-01-04	4	ITOS	iTeos Therapeutics, Inc. Common Stock	S - Sale		-12,829	4,515,075	-0.28	46.47	-596,164	209,815,535
2022-01-06	2022-01-04	4	ITOS	iTeos Therapeutics, Inc. Common Stock	S - Sale		-11,318	4,527,904	-0.25	45.32	-512,932	205,204,609
2022-01-06	2022-01-04	4	ITOS	iTeos Therapeutics, Inc. Common Stock	S - Sale		-32,396	4,539,222	-0.71	43.20	-1,399,507	196,094,390
2022-01-06	2022-01-04	4	ITOS	iTeos Therapeutics, Inc. Common Stock	S - Sale		-158,579	4,571,618	-3.35	42.05	-6,668,247	192,236,537
2021-12-07	2021-12-07	4	ITOS	iTeos Therapeutics, Inc. Common Stock	S - Sale	X	-2,499	4,730,197	-0.05	34.11	-85,241	161,347,020
2021-12-07	2021-12-07	4	ITOS	iTeos Therapeutics, Inc. Common Stock	S - Sale	X	-30,059	4,732,696	-0.63	33.15	-996,456	156,888,872
2021-12-07	2021-12-06	4	ITOS	iTeos Therapeutics, Inc. Common Stock	S - Sale	X	-100	4,762,755	0.00	35.04	-3,504	166,886,935
2021-12-07	2021-12-06	4	ITOS	iTeos Therapeutics, Inc. Common Stock	S - Sale	X	-850	4,762,855	-0.02	34.08	-28,968	162,318,098
2021-12-07	2021-12-06	4	ITOS	iTeos Therapeutics, Inc. Common Stock	S - Sale	X	-1,960	4,763,705	-0.04	33.57	-65,797	159,917,577
2021-12-07	2021-12-06	4	ITOS	iTeos Therapeutics, Inc. Common Stock	S - Sale	X	-14,173	4,765,665	-0.30	32.35	-458,497	154,169,263
2021-12-07	2021-12-03	4	ITOS	iTeos Therapeutics, Inc. Common Stock	S - Sale	X	-300	4,779,838	-0.01	36.26	-10,878	173,316,926
2021-12-07	2021-12-03	4	ITOS	iTeos Therapeutics, Inc. Common Stock	S - Sale	X	-4,047	4,780,138	-0.08	35.44	-143,426	169,408,091
2021-12-07	2021-12-03	4	ITOS	iTeos Therapeutics, Inc. Common Stock	S - Sale	X	-29,402	4,784,185	-0.61	34.68	-1,019,661	165,915,536
2021-12-02	2021-12-02	4	ITOS	iTeos Therapeutics, Inc. Common Stock	S - Sale	X	-12,434	4,813,587	-0.26	34.83	-433,076	167,657,235
2021-12-02	2021-12-02	4	ITOS	iTeos Therapeutics, Inc. Common Stock	S - Sale	X	-49,796	4,826,021	-1.02	33.74	-1,680,117	162,829,949
2021-12-02	2021-12-01	4	ITOS	iTeos Therapeutics, Inc. Common Stock	S - Sale	X	-1,500	4,875,817	-0.03	35.34	-53,010	172,311,373
2021-12-02	2021-12-01	4	ITOS	iTeos Therapeutics, Inc. Common Stock	S - Sale	X	-9,131	4,877,317	-0.19	34.61	-316,024	168,803,941
2021-12-02	2021-12-01	4	ITOS	iTeos Therapeutics, Inc. Common Stock	S - Sale	X	-10,111	4,886,448	-0.21	33.82	-341,954	165,259,671
2021-12-02	2021-11-30	4	ITOS	iTeos Therapeutics, Inc. Common Stock	S - Sale	X	-46,992	4,896,559	-0.95	35.19	-1,653,648	172,309,911
2021-12-02	2021-11-30	4	ITOS	iTeos Therapeutics, Inc. Common Stock	S - Sale	X	-9,809	4,943,551	-0.20	34.62	-339,588	171,145,736
2021-11-30	2021-11-29	4	ITOS	iTeos Therapeutics, Inc. Common Stock	S - Sale	X	-500	4,953,360	-0.01	35.37	-17,685	175,200,343
2021-11-30	2021-11-29	4	ITOS	iTeos Therapeutics, Inc. Common Stock	S - Sale	X	-16,856	4,953,860	-0.34	34.46	-580,858	170,710,016
2021-11-30	2021-11-26	4	ITOS	iTeos Therapeutics, Inc. Common Stock	S - Sale	X	-10,258	4,970,716	-0.21	36.03	-369,596	179,094,897
2021-11-30	2021-11-26	4	ITOS	iTeos Therapeutics, Inc. Common Stock	S - Sale	X	-10,952	4,980,974	-0.22	35.49	-388,686	176,774,767
2021-11-24	2021-11-24	4	ITOS	iTeos Therapeutics, Inc. Common Stock	S - Sale	X	-21,965	4,991,926	-0.44	37.02	-813,144	184,801,101
2021-11-24	2021-11-24	4	ITOS	iTeos Therapeutics, Inc. Common Stock	S - Sale	X	-30,696	5,013,891	-0.61	36.05	-1,106,591	180,750,771
2021-11-24	2021-11-24	4	ITOS	iTeos Therapeutics, Inc. Common Stock	S - Sale	X	-8,147	5,044,587	-0.16	35.20	-286,774	177,569,462
2021-11-24	2021-11-23	4	ITOS	iTeos Therapeutics, Inc. Common Stock	S - Sale	X	-600	5,052,734	-0.01	36.50	-21,900	184,424,791
2021-11-24	2021-11-23	4	ITOS	iTeos Therapeutics, Inc. Common Stock	S - Sale	X	-32,876	5,053,334	-0.65	36.21	-1,190,440	182,981,224
2021-11-24	2021-11-22	4	ITOS	iTeos Therapeutics, Inc. Common Stock	S - Sale	X	-19,758	5,086,210	-0.39	37.81	-747,050	192,309,600
2021-11-24	2021-11-22	4	ITOS	iTeos Therapeutics, Inc. Common Stock	S - Sale	X	-15,575	5,105,986	-0.30	37.16	-578,767	189,738,440
2021-11-24	2021-11-17	4	ITOS	iTeos Therapeutics, Inc. Common Stock	J - Other		-15,671	5,121,543	-0.31
2021-11-04	2021-11-02	4	TRDA	Entrada Therapeutics, Inc. Series B Preferred Stock	C - Conversion		-3,683,241	0	-100.00
2021-11-04	2021-11-02	4	TRDA	Entrada Therapeutics, Inc. Series A Preferred Stock	C - Conversion		-27,617,675	0	-100.00
2021-11-04	2021-11-02	4	TRDA	Entrada Therapeutics, Inc. Common Stock	P - Purchase		100,000	4,425,784	2.31	20.00	2,000,000	88,515,680
2021-11-04	2021-11-02	4	TRDA	Entrada Therapeutics, Inc. Common Stock	C - Conversion		509,024	4,325,784	13.34
2021-11-04	2021-11-02	4	TRDA	Entrada Therapeutics, Inc. Common Stock	C - Conversion		3,816,760	3,816,760
2021-10-18	2021-10-18	4	ITOS	iTeos Therapeutics, Inc. Common Stock	S - Sale	X	-10,320	5,137,214	-0.20	27.14	-280,085	139,423,988
2021-10-18	2021-10-15	4	ITOS	iTeos Therapeutics, Inc. Common Stock	S - Sale	X	-3,413	5,147,534	-0.07	28.01	-95,598	144,182,427
2021-10-18	2021-10-15	4	ITOS	iTeos Therapeutics, Inc. Common Stock	S - Sale	X	-14,882	5,150,947	-0.29	27.53	-409,701	141,805,571
2021-10-14	2021-10-14	4	ITOS	iTeos Therapeutics, Inc. Common Stock	S - Sale	X	-45,719	5,165,829	-0.88	27.30	-1,248,129	141,027,132
2021-10-14	2021-10-13	4	ITOS	iTeos Therapeutics, Inc. Common Stock	S - Sale	X	-35,023	5,211,548	-0.67	27.13	-950,174	141,389,297
2021-10-14	2021-10-12	4	ITOS	iTeos Therapeutics, Inc. Common Stock	S - Sale	X	-14,260	5,246,571	-0.27	27.09	-386,303	142,129,608
2021-10-12	2021-10-11	4	ITOS	iTeos Therapeutics, Inc. Common Stock	S - Sale	X	-81,684	5,260,831	-1.53	27.24	-2,225,072	143,305,036
2021-10-12	2021-10-08	4	ITOS	iTeos Therapeutics, Inc. Common Stock	S - Sale	X	-3,400	5,342,515	-0.06	27.01	-91,834	144,301,330
2021-10-12	2021-10-07	4	ITOS	iTeos Therapeutics, Inc. Common Stock	S - Sale	X	-1,922	5,345,915	-0.04	27.00	-51,894	144,339,705
2021-10-05	2021-10-04	4	ITOS	iTeos Therapeutics, Inc. Common Stock	S - Sale	X	-34,659	5,347,837	-0.64	27.06	-937,873	144,712,469
2021-10-05	2021-10-01	4	ITOS	iTeos Therapeutics, Inc. Common Stock	S - Sale	X	-11,471	5,382,496	-0.21	27.00	-309,717	145,327,392
2021-09-30	2021-09-30	4	ITOS	iTeos Therapeutics, Inc. Common Stock	S - Sale	X	-3,836	5,393,967	-0.07	27.00	-103,572	145,637,109
2021-09-30	2021-09-28	4	ITOS	iTeos Therapeutics, Inc. Common Stock	S - Sale	X	-32,154	5,397,803	-0.59	27.00	-868,158	145,740,681
2021-09-27	2021-09-27	4	ITOS	iTeos Therapeutics, Inc. Common Stock	S - Sale	X	-19,455	5,429,957	-0.36	27.09	-527,036	147,097,535
2021-09-27	2021-09-24	4	ITOS	iTeos Therapeutics, Inc. Common Stock	S - Sale	X	-8,221	5,449,412	-0.15	27.81	-228,626	151,548,148
2021-09-27	2021-09-23	4	ITOS	iTeos Therapeutics, Inc. Common Stock	S - Sale	X	-1,200	5,457,633	-0.02	28.38	-34,056	154,887,625
2021-09-27	2021-09-23	4	ITOS	iTeos Therapeutics, Inc. Common Stock	S - Sale	X	-60,600	5,458,833	-1.10	27.96	-1,694,376	152,628,971
2021-09-23	2021-09-22	4	ITOS	iTeos Therapeutics, Inc. Common Stock	S - Sale	X	-23,921	5,519,433	-0.43	27.54	-658,784	152,005,185
2021-09-23	2021-09-21	4	ITOS	iTeos Therapeutics, Inc. Common Stock	S - Sale	X	-32,858	5,543,354	-0.59	27.47	-902,609	152,275,934
2021-09-20	2021-09-16	4	CGEM	Cullinan Oncology, Inc. Common Stock	S - Sale	X	-3,124	7,648,268	-0.04	29.06	-90,783	222,258,668
2021-09-20	2021-09-16	4	CGEM	Cullinan Oncology, Inc. Common Stock	S - Sale	X	-432	244,551	-0.18	29.06	-12,554	7,106,652
2021-09-20	2021-09-20	4	ITOS	iTeos Therapeutics, Inc. Common Stock	S - Sale	X	-22,930	5,576,212	-0.41	27.84	-638,371	155,241,742
2021-09-20	2021-09-20	4	ITOS	iTeos Therapeutics, Inc. Common Stock	S - Sale	X	-17,743	5,599,142	-0.32	27.03	-479,593	151,344,808
2021-09-20	2021-09-17	4	ITOS	iTeos Therapeutics, Inc. Common Stock	S - Sale	X	-76,473	5,616,885	-1.34	28.82	-2,203,952	161,878,626
2021-09-20	2021-09-16	4	ITOS	iTeos Therapeutics, Inc. Common Stock	S - Sale	X	-35,565	5,693,358	-0.62	28.47	-1,012,536	162,089,902
2021-09-16	2021-09-15	4	CGEM	Cullinan Oncology, Inc. Common Stock	S - Sale	X	-6,425	7,651,392	-0.08	29.16	-187,353	223,114,591
2021-09-16	2021-09-15	4	CGEM	Cullinan Oncology, Inc. Common Stock	S - Sale	X	-888	244,983	-0.36	29.16	-25,894	7,143,704
2021-09-16	2021-09-14	4	CGEM	Cullinan Oncology, Inc. Common Stock	S - Sale	X	-7,106	7,657,817	-0.09	29.17	-207,282	223,378,522
2021-09-16	2021-09-14	4	CGEM	Cullinan Oncology, Inc. Common Stock	S - Sale	X	-982	245,871	-0.40	29.17	-28,645	7,172,057
2021-09-16	2021-09-15	4	ITOS	iTeos Therapeutics, Inc. Common Stock	S - Sale	X	-1,659	5,728,923	-0.03	28.15	-46,701	161,269,182
2021-09-16	2021-09-15	4	ITOS	iTeos Therapeutics, Inc. Common Stock	S - Sale	X	-38,677	5,730,582	-0.67	27.79	-1,074,834	159,252,874
2021-09-16	2021-09-14	4	ITOS	iTeos Therapeutics, Inc. Common Stock	S - Sale	X	-6,063	5,769,259	-0.10	27.99	-169,703	161,481,559
2021-09-16	2021-09-14	4	ITOS	iTeos Therapeutics, Inc. Common Stock	S - Sale	X	-30,018	5,775,322	-0.52	27.50	-825,495	158,821,355
2021-09-13	2021-09-13	4	CGEM	Cullinan Oncology, Inc. Common Stock	S - Sale	X	-3,595	7,664,923	-0.05	29.10	-104,614	223,049,259
2021-09-13	2021-09-13	4	CGEM	Cullinan Oncology, Inc. Common Stock	S - Sale	X	-497	246,853	-0.20	29.10	-14,463	7,183,422
2021-09-13	2021-09-10	4	CGEM	Cullinan Oncology, Inc. Common Stock	S - Sale	X	-5,931	7,668,518	-0.08	29.04	-172,236	222,693,763
2021-09-13	2021-09-10	4	CGEM	Cullinan Oncology, Inc. Common Stock	S - Sale	X	-820	247,350	-0.33	29.04	-23,813	7,183,044
2021-09-13	2021-09-09	4	CGEM	Cullinan Oncology, Inc. Common Stock	S - Sale	X	-13,727	7,674,449	-0.18	29.35	-402,887	225,245,078
2021-09-13	2021-09-09	4	CGEM	Cullinan Oncology, Inc. Common Stock	S - Sale	X	-1,898	248,170	-0.76	29.35	-55,706	7,283,790
2021-09-13	2021-09-13	4	ITOS	iTeos Therapeutics, Inc. Common Stock	S - Sale	X	-35,785	5,805,340	-0.61	27.64	-989,097	160,459,598
2021-09-13	2021-09-10	4	ITOS	iTeos Therapeutics, Inc. Common Stock	S - Sale	X	-11,330	5,841,125	-0.19	28.73	-325,511	167,815,521
2021-09-13	2021-09-10	4	ITOS	iTeos Therapeutics, Inc. Common Stock	S - Sale	X	-11,313	5,852,455	-0.19	27.86	-315,180	163,049,396
2021-09-13	2021-09-09	4	ITOS	iTeos Therapeutics, Inc. Common Stock	S - Sale	X	-38,028	5,863,768	-0.64	28.97	-1,101,671	169,873,359
2021-09-08	2021-09-08	4	CGEM	Cullinan Oncology, Inc. Common Stock	S - Sale	X	-10,842	7,688,176	-0.14	29.11	-315,611	223,802,803
2021-09-08	2021-09-08	4	CGEM	Cullinan Oncology, Inc. Common Stock	S - Sale	X	-1,499	250,068	-0.60	29.11	-43,636	7,279,479
2021-09-08	2021-09-07	4	CGEM	Cullinan Oncology, Inc. Common Stock	S - Sale	X	-25,067	7,699,018	-0.32	29.04	-727,946	223,579,483
2021-09-08	2021-09-07	4	CGEM	Cullinan Oncology, Inc. Common Stock	S - Sale	X	-3,465	251,567	-1.36	29.04	-100,624	7,305,506
2021-09-08	2021-09-03	4	CGEM	Cullinan Oncology, Inc. Common Stock	S - Sale	X	-12,731	7,724,085	-0.16	29.60	-376,838	228,632,916
2021-09-08	2021-09-03	4	CGEM	Cullinan Oncology, Inc. Common Stock	S - Sale	X	-1,760	255,032	-0.69	29.60	-52,096	7,548,947
2021-09-08	2021-09-08	4	ITOS	iTeos Therapeutics, Inc. Common Stock	S - Sale	X	-1,573	5,901,796	-0.03	29.10	-45,774	171,742,264
2021-09-08	2021-09-08	4	ITOS	iTeos Therapeutics, Inc. Common Stock	S - Sale	X	-18,663	5,903,369	-0.32	28.61	-533,948	168,895,387
2021-09-08	2021-09-07	4	ITOS	iTeos Therapeutics, Inc. Common Stock	J - Other		-31,340	5,922,032	-0.53
2021-09-08	2021-09-07	4	ITOS	iTeos Therapeutics, Inc. Common Stock	S - Sale	X	-50,996	5,953,372	-0.85	29.18	-1,488,063	173,719,395
2021-09-02	2021-09-02	4	CGEM	Cullinan Oncology, Inc. Common Stock	S - Sale	X	-15,757	7,736,816	-0.20	29.46	-464,201	227,926,599
2021-09-02	2021-09-02	4	CGEM	Cullinan Oncology, Inc. Common Stock	S - Sale	X	-2,178	256,792	-0.84	29.46	-64,164	7,565,092
2021-09-02	2021-09-01	4	CGEM	Cullinan Oncology, Inc. Common Stock	S - Sale	X	-5,714	7,752,573	-0.07	29.47	-168,392	228,468,326
2021-09-02	2021-09-01	4	CGEM	Cullinan Oncology, Inc. Common Stock	S - Sale		-790	258,970	-0.30	29.47	-23,281	7,631,846
2021-09-02	2021-08-31	4	CGEM	Cullinan Oncology, Inc. Common Stock	S - Sale	X	-1,553	7,758,287	-0.02	30.14	-46,807	233,834,770
2021-09-02	2021-08-31	4	CGEM	Cullinan Oncology, Inc. Common Stock	S - Sale	X	-215	259,760	-0.08	30.14	-6,480	7,829,166
2021-09-02	2021-08-31	4	CGEM	Cullinan Oncology, Inc. Common Stock	S - Sale	X	-1,285	7,759,840	-0.02	29.43	-37,818	228,372,091
2021-09-02	2021-08-31	4	CGEM	Cullinan Oncology, Inc. Common Stock	S - Sale	X	-177	259,975	-0.07	29.43	-5,209	7,651,064
2021-08-31	2021-08-30	4	CGEM	Cullinan Oncology, Inc. Common Stock	S - Sale	X	-31,001	7,761,125	-0.40	29.30	-908,329	227,400,962
2021-08-31	2021-08-30	4	CGEM	Cullinan Oncology, Inc. Common Stock	S - Sale	X	-4,285	260,152	-1.62	29.30	-125,550	7,622,454
2021-08-31	2021-08-27	4	CGEM	Cullinan Oncology, Inc. Common Stock	S - Sale	X	-13,357	7,792,126	-0.17	29.09	-388,555	226,672,945
2021-08-31	2021-08-27	4	CGEM	Cullinan Oncology, Inc. Common Stock	S - Sale	X	-1,846	264,437	-0.69	29.09	-53,700	7,692,472
2021-08-25	2021-08-25	4	CGEM	Cullinan Oncology, Inc. Common Stock	S - Sale	X	-1,713	7,805,483	-0.02	29.09	-49,831	227,061,500
2021-08-25	2021-08-25	4	CGEM	Cullinan Oncology, Inc. Common Stock	S - Sale	X	-237	266,283	-0.09	29.09	-6,894	7,746,172
2021-08-25	2021-08-24	4	CGEM	Cullinan Oncology, Inc. Common Stock	S - Sale	X	-50,882	7,807,196	-0.65	29.48	-1,500,001	230,156,138
2021-08-25	2021-08-24	4	CGEM	Cullinan Oncology, Inc. Common Stock	S - Sale	X	-7,025	266,520	-2.57	29.48	-207,097	7,857,010
2021-08-25	2021-08-23	4	CGEM	Cullinan Oncology, Inc. Common Stock	S - Sale	X	-53,359	7,858,018	-0.67	29.11	-1,553,280	228,746,904
2021-08-25	2021-08-23	4	CGEM	Cullinan Oncology, Inc. Common Stock	S - Sale	X	-7,376	273,545	-2.63	29.11	-214,715	7,962,895
2021-08-12	2021-08-11	4	CGEM	Cullinan Oncology, Inc. Common Stock	S - Sale	X	-2,510	7,911,377	-0.03	29.05	-72,916	229,825,502
2021-08-12	2021-08-11	4	CGEM	Cullinan Oncology, Inc. Common Stock	S - Sale	X	-347	280,921	-0.12	29.05	-10,080	8,160,755
2021-07-13	2021-07-12	4	RPTX	Repare Therapeutics Inc. Common Shares	S - Sale	X	-711	3,882,485	-0.02	34.10	-24,245	132,392,738
2021-07-13	2021-07-12	4	RPTX	Repare Therapeutics Inc. Common Shares	S - Sale	X	-57,301	3,883,196	-1.45	33.58	-1,924,168	130,397,722
2021-07-13	2021-07-09	4	RPTX	Repare Therapeutics Inc. Common Shares	S - Sale	X	-4,067	3,940,497	-0.10	33.06	-134,455	130,272,831
2021-06-30	2021-06-29	4	RPTX	Repare Therapeutics Inc. Common Shares	S - Sale	X	-2,700	3,944,564	-0.07	33.29	-89,883	131,314,536
2021-06-30	2021-06-28	4	RPTX	Repare Therapeutics Inc. Common Shares	S - Sale	X	-2,700	3,947,264	-0.07	34.82	-94,014	137,443,732
2021-06-30	2021-06-28	4	RPTX	Repare Therapeutics Inc. Common Shares	S - Sale	X	-13,800	3,949,964	-0.35	34.06	-470,028	134,535,774
2021-06-28	2021-06-25	4	RPTX	Repare Therapeutics Inc. Common Shares	S - Sale	X	-22,567	3,963,764	-0.57	33.51	-756,220	132,825,732
2021-06-28	2021-06-24	4	RPTX	Repare Therapeutics Inc. Common Shares	S - Sale	X	-6,121	3,986,331	-0.15	33.53	-205,237	133,661,678
2021-06-23	2021-06-23	4	RPTX	Repare Therapeutics Inc. Common Shares	S - Sale	X	-1,410	3,992,452	-0.04	32.98	-46,502	131,671,067
2021-06-23	2021-06-22	4	RPTX	Repare Therapeutics Inc. Common Shares	S - Sale	X	-429	3,993,862	-0.01	34.09	-14,625	136,150,756
2021-06-23	2021-06-22	4	RPTX	Repare Therapeutics Inc. Common Shares	S - Sale	X	-3,371	3,994,291	-0.08	33.36	-112,457	133,249,548
2021-06-23	2021-06-21	4	RPTX	Repare Therapeutics Inc. Common Shares	S - Sale	X	-31,788	3,997,662	-0.79	34.63	-1,100,818	138,439,035
2021-06-23	2021-06-21	4	RPTX	Repare Therapeutics Inc. Common Shares	S - Sale	X	-5,800	4,029,450	-0.14	33.80	-196,040	136,195,410
2021-06-21	2021-06-18	4	RPTX	Repare Therapeutics Inc. Common Shares	S - Sale	X	-3,199	4,035,250	-0.08	34.03	-108,862	137,319,558
2021-06-21	2021-06-18	4	RPTX	Repare Therapeutics Inc. Common Shares	S - Sale	X	-5,801	4,038,449	-0.14	33.46	-194,101	135,126,504
2021-06-21	2021-06-17	4	RPTX	Repare Therapeutics Inc. Common Shares	S - Sale	X	-1,708	4,044,250	-0.04	34.12	-58,277	137,989,810
2021-06-21	2021-06-17	4	RPTX	Repare Therapeutics Inc. Common Shares	S - Sale	X	-30,810	4,045,958	-0.76	33.78	-1,040,762	136,672,461
2021-06-16	2021-06-16	4	RPTX	Repare Therapeutics Inc. Common Shares	S - Sale	X	-4,227	4,076,768	-0.10	33.33	-140,886	135,878,677
2021-06-16	2021-06-14	4	RPTX	Repare Therapeutics Inc. Common Shares	S - Sale	X	-2,000	4,080,995	-0.05	33.09	-66,180	135,040,125
2021-06-10	2021-06-09	4	RPTX	Repare Therapeutics Inc. Common Shares	S - Sale	X	-24,368	4,082,995	-0.59	34.79	-847,763	142,047,396
2021-06-10	2021-06-09	4	RPTX	Repare Therapeutics Inc. Common Shares	S - Sale	X	-10,862	4,107,363	-0.26	34.42	-373,870	141,375,434
2021-06-10	2021-06-08	4	RPTX	Repare Therapeutics Inc. Common Shares	S - Sale	X	-17,155	4,118,225	-0.41	33.41	-573,149	137,589,897
2021-06-10	2021-06-08	4	RPTX	Repare Therapeutics Inc. Common Shares	S - Sale	X	-9,045	4,135,380	-0.22	32.80	-296,676	135,640,464
2021-06-07	2021-06-07	4	RPTX	Repare Therapeutics Inc. Common Shares	S - Sale	X	-19,017	4,144,425	-0.46	32.96	-626,800	136,600,248
2021-06-07	2021-06-07	4	RPTX	Repare Therapeutics Inc. Common Shares	S - Sale	X	-1,700	4,163,442	-0.04	32.25	-54,825	134,271,004
2021-06-07	2021-06-07	4	RPTX	Repare Therapeutics Inc. Common Shares	S - Sale	X	-2,400	4,165,142	-0.06	30.74	-73,776	128,036,465
2021-06-07	2021-06-04	4	RPTX	Repare Therapeutics Inc. Common Shares	S - Sale	X	-4,694	4,167,542	-0.11	31.28	-146,828	130,360,714
2021-06-07	2021-06-04	4	RPTX	Repare Therapeutics Inc. Common Shares	S - Sale	X	-8,042	4,172,236	-0.19	30.80	-247,694	128,504,869
2021-06-07	2021-06-03	4	RPTX	Repare Therapeutics Inc. Common Shares	S - Sale	X	-22,296	4,180,278	-0.53	31.92	-711,688	133,434,474
2021-06-02	2021-06-02	4	RPTX	Repare Therapeutics Inc. Common Shares	S - Sale	X	-297	4,202,574	-0.01	32.42	-9,629	136,247,449
2021-06-02	2021-06-02	4	RPTX	Repare Therapeutics Inc. Common Shares	S - Sale	X	-5,918	4,202,871	-0.14	31.83	-188,370	133,777,384
2021-06-02	2021-06-01	4	RPTX	Repare Therapeutics Inc. Common Shares	S - Sale	X	-15,141	4,208,789	-0.36	32.50	-492,082	136,785,642
2021-06-02	2021-05-28	4	RPTX	Repare Therapeutics Inc. Common Shares	S - Sale	X	-16,742	4,223,930	-0.39	32.67	-546,961	137,995,793
2021-06-02	2021-06-02	4	HARP	Harpoon Therapeutics, Inc. Common Stock	S - Sale	X	-25,118	6,328,095	-0.40	20.50	-514,919	129,725,948
2021-06-02	2021-06-01	4	HARP	Harpoon Therapeutics, Inc. Common Stock	S - Sale	X	-18,491	6,353,213	-0.29	20.44	-377,956	129,859,674
2021-06-02	2021-05-28	4	HARP	Harpoon Therapeutics, Inc. Common Stock	S - Sale	X	-100	6,371,704	0.00	22.60	-2,260	144,000,510
2021-06-02	2021-05-28	4	HARP	Harpoon Therapeutics, Inc. Common Stock	S - Sale	X	-3,100	6,371,804	-0.05	21.92	-67,952	139,669,944
2021-06-02	2021-05-28	4	HARP	Harpoon Therapeutics, Inc. Common Stock	S - Sale	X	-10,685	6,374,904	-0.17	20.88	-223,103	133,107,996
2021-05-27	2021-05-25	4	ALVR	Allovir, Inc. Stock Option (Right to Buy)	A - Award		22,500	22,500
2021-05-27	2021-05-27	4	HARP	Harpoon Therapeutics, Inc. Common Stock	S - Sale	X	-13,961	6,385,589	-0.22	20.26	-282,850	129,372,033
2021-05-27	2021-05-26	4	HARP	Harpoon Therapeutics, Inc. Common Stock	S - Sale	X	-3,198	6,399,550	-0.05	20.04	-64,088	128,246,982
2021-05-27	2021-05-27	4	RPTX	Repare Therapeutics Inc. Common Shares	S - Sale	X	-3,624	4,240,672	-0.09	33.16	-120,172	140,620,684
2021-05-27	2021-05-27	4	RPTX	Repare Therapeutics Inc. Common Shares	S - Sale	X	-4,327	4,244,296	-0.10	32.81	-141,969	139,255,352
2021-05-27	2021-05-26	4	RPTX	Repare Therapeutics Inc. Common Shares	S - Sale	X	-1,704	4,248,623	-0.04	33.01	-56,249	140,247,045
2021-05-27	2021-05-26	4	RPTX	Repare Therapeutics Inc. Common Shares	S - Sale	X	-22,332	4,250,327	-0.52	32.74	-731,150	139,155,706
2021-05-27	2021-05-25	4	RPTX	Repare Therapeutics Inc. Common Shares	S - Sale	X	-100	4,272,659	0.00	33.59	-3,359	143,518,616
2021-05-27	2021-05-25	4	RPTX	Repare Therapeutics Inc. Common Shares	S - Sale	X	-6,472	4,272,759	-0.15	32.87	-212,735	140,445,588
2021-05-24	2021-05-24	4	HARP	Harpoon Therapeutics, Inc. Common Stock	S - Sale	X	-5,000	6,402,748	-0.08	20.12	-100,600	128,823,290
2021-05-24	2021-05-21	4	HARP	Harpoon Therapeutics, Inc. Common Stock	S - Sale	X	-10,907	6,407,748	-0.17	20.21	-220,430	129,500,587
2021-05-24	2021-05-24	4	RPTX	Repare Therapeutics Inc. Common Shares	S - Sale	X	-18,653	4,279,231	-0.43	34.28	-639,425	146,692,039
2021-05-24	2021-05-24	4	RPTX	Repare Therapeutics Inc. Common Shares	S - Sale	X	-3,547	4,297,884	-0.08	33.30	-118,115	143,119,537
2021-05-24	2021-05-21	4	RPTX	Repare Therapeutics Inc. Common Shares	S - Sale	X	-302,669	4,301,431	-6.57	34.80	-10,532,881	149,689,799
2021-05-20	2021-05-20	4	HARP	Harpoon Therapeutics, Inc. Common Stock	S - Sale	X	-11,713	6,418,655	-0.18	20.34	-238,242	130,555,443
2021-05-20	2021-05-19	4	HARP	Harpoon Therapeutics, Inc. Common Stock	S - Sale	X	-17,833	6,430,368	-0.28	20.39	-363,615	131,115,204
2021-05-20	2021-05-18	4	HARP	Harpoon Therapeutics, Inc. Common Stock	S - Sale	X	-18,402	6,448,201	-0.28	20.67	-380,369	133,284,315
2021-05-20	2021-05-20	4	RPTX	Repare Therapeutics Inc. Common Shares	S - Sale	X	-600	4,604,100	-0.01	35.19	-21,114	162,018,279
2021-05-20	2021-05-20	4	RPTX	Repare Therapeutics Inc. Common Shares	S - Sale	X	-9,357	4,604,700	-0.20	34.66	-324,314	159,598,902
2021-05-20	2021-05-19	4	RPTX	Repare Therapeutics Inc. Common Shares	S - Sale	X	-4,400	4,614,057	-0.10	35.00	-154,000	161,491,995
2021-05-20	2021-05-19	4	RPTX	Repare Therapeutics Inc. Common Shares	S - Sale	X	-9,143	4,618,457	-0.20	34.23	-312,965	158,089,783
2021-05-20	2021-05-18	4	RPTX	Repare Therapeutics Inc. Common Shares	J - Other	X	-21,834	4,627,600	-0.47
2021-05-20	2021-05-18	4	RPTX	Repare Therapeutics Inc. Common Shares	S - Sale	X	-90	4,649,434	0.00	35.14	-3,163	163,381,111
2021-05-20	2021-05-18	4	RPTX	Repare Therapeutics Inc. Common Shares	S - Sale	X	-8,541	4,649,524	-0.18	34.61	-295,604	160,920,026
2021-05-20	2021-05-18	4	RPTX	Repare Therapeutics Inc. Common Shares	S - Sale	X	-14,773	4,658,065	-0.32	33.90	-500,805	157,908,404
2021-05-17	2021-05-17	4	HARP	Harpoon Therapeutics, Inc. Common Stock	S - Sale	X	-4,666	6,466,603	-0.07	20.07	-93,647	129,784,722
2021-05-17	2021-05-14	4	HARP	Harpoon Therapeutics, Inc. Common Stock	S - Sale	X	-6,900	6,471,269	-0.11	20.04	-138,276	129,684,231
2021-05-17	2021-05-13	4	HARP	Harpoon Therapeutics, Inc. Common Stock	S - Sale	X	-4,855	6,478,169	-0.07	20.06	-97,391	129,952,070
2021-05-12	2021-05-12	4	HARP	Harpoon Therapeutics, Inc. Common Stock	S - Sale	X	-29,684	6,483,024	-0.46	20.53	-609,413	133,096,483
2021-05-12	2021-05-11	4	HARP	Harpoon Therapeutics, Inc. Common Stock	S - Sale	X	-7,672	6,512,708	-0.12	21.51	-165,025	140,088,349
2021-05-12	2021-05-11	4	HARP	Harpoon Therapeutics, Inc. Common Stock	S - Sale	X	-13,773	6,520,380	-0.21	20.96	-288,682	136,667,165
2021-05-12	2021-05-10	4	HARP	Harpoon Therapeutics, Inc. Common Stock	S - Sale	X	-411	6,534,153	-0.01	22.46	-9,231	146,757,076
2021-05-12	2021-05-10	4	HARP	Harpoon Therapeutics, Inc. Common Stock	S - Sale	X	-16,722	6,534,564	-0.26	21.78	-364,205	142,322,804
2021-05-06	2021-05-05	4	HARP	Harpoon Therapeutics, Inc. Common Stock	S - Sale	X	-59	6,551,286	0.00	23.09	-1,362	151,269,194
2021-05-06	2021-05-05	4	HARP	Harpoon Therapeutics, Inc. Common Stock	S - Sale	X	-10,113	6,551,345	-0.15	22.52	-227,745	147,536,289
2021-05-06	2021-05-04	4	HOWL	Werewolf Therapeutics, Inc. Series B Preferred Stock	C - Conversion		-12,899,925	0	-100.00
2021-05-06	2021-05-04	4	HOWL	Werewolf Therapeutics, Inc. Series A Preferred Stock	C - Conversion		-38,817,998	0	-100.00
2021-05-06	2021-05-04	4	HOWL	Werewolf Therapeutics, Inc. Common Stock	P - Purchase		245,000	6,672,183	3.81	16.00	3,920,000	106,754,928
2021-05-06	2021-05-04	4	HOWL	Werewolf Therapeutics, Inc. Common Stock	C - Conversion		1,488,033	6,427,183	30.13
2021-05-06	2021-05-04	4	HOWL	Werewolf Therapeutics, Inc. Common Stock	C - Conversion		4,477,742	4,939,150	970.45
2021-05-04	2021-05-04	4	HARP	Harpoon Therapeutics, Inc. Common Stock	S - Sale	X	-3,500	6,561,458	-0.05	23.33	-81,655	153,078,815
2021-05-04	2021-05-04	4	HARP	Harpoon Therapeutics, Inc. Common Stock	S - Sale	X	-26,230	6,564,958	-0.40	23.03	-604,077	151,190,983
2021-05-04	2021-05-03	4	HARP	Harpoon Therapeutics, Inc. Common Stock	S - Sale	X	-4,401	6,591,188	-0.07	23.45	-103,203	154,563,359
2021-05-04	2021-05-03	4	HARP	Harpoon Therapeutics, Inc. Common Stock	S - Sale	X	-26,365	6,595,589	-0.40	23.03	-607,186	151,896,415
2021-05-04	2021-04-30	4	HARP	Harpoon Therapeutics, Inc. Common Stock	S - Sale	X	-268,023	6,621,954	-3.89	22.35	-5,990,314	148,000,672
2021-04-29		3	HOWL	Werewolf Therapeutics, Inc. Common Stock				461,408
2021-04-29	2021-04-29	4	HARP	Harpoon Therapeutics, Inc. Common Stock	S - Sale	X	-21,781	6,889,977	-0.32	22.54	-490,944	155,300,082
2021-04-29	2021-04-29	4	HARP	Harpoon Therapeutics, Inc. Common Stock	S - Sale	X	-45,511	6,911,758	-0.65	22.02	-1,002,152	152,196,911
2021-04-29	2021-04-28	4	HARP	Harpoon Therapeutics, Inc. Common Stock	S - Sale	X	-36,803	6,957,269	-0.53	22.01	-810,034	153,129,491
2021-04-29	2021-04-28	4	HARP	Harpoon Therapeutics, Inc. Common Stock	S - Sale	X	-14,219	6,994,072	-0.20	21.64	-307,699	151,351,718
2021-04-29	2021-04-27	4	HARP	Harpoon Therapeutics, Inc. Common Stock	S - Sale	X	-8,328	7,008,291	-0.12	21.26	-177,053	148,996,267
2021-04-29	2021-04-27	4	HARP	Harpoon Therapeutics, Inc. Common Stock	S - Sale	X	-3,501	7,016,619	-0.05	20.99	-73,486	147,278,833
2021-04-22	2021-04-21	4	HARP	Harpoon Therapeutics, Inc. Common Stock	S - Sale	X	-555	7,020,120	-0.01	19.48	-10,811	136,751,938
2021-04-22	2021-04-21	4	HARP	Harpoon Therapeutics, Inc. Common Stock	S - Sale	X	-8,417	7,020,675	-0.12	18.94	-159,418	132,971,584
2021-04-20	2021-04-20	4	HARP	Harpoon Therapeutics, Inc. Common Stock	S - Sale	X	-834	7,029,092	-0.01	19.09	-15,921	134,185,366
2021-04-20	2021-04-20	4	HARP	Harpoon Therapeutics, Inc. Common Stock	S - Sale	X	-21,415	7,029,926	-0.30	18.70	-400,460	131,459,616
2021-04-20	2021-04-19	4	HARP	Harpoon Therapeutics, Inc. Common Stock	S - Sale	X	-100	7,051,341	0.00	20.08	-2,008	141,590,927
2021-04-20	2021-04-19	4	HARP	Harpoon Therapeutics, Inc. Common Stock	S - Sale	X	-9,956	7,051,441	-0.14	19.29	-192,051	136,022,297
2021-04-20	2021-04-16	4	HARP	Harpoon Therapeutics, Inc. Common Stock	S - Sale	X	-300	7,061,397	0.00	20.56	-6,168	145,182,322
2021-04-20	2021-04-16	4	HARP	Harpoon Therapeutics, Inc. Common Stock	S - Sale	X	-5,547	7,061,697	-0.08	19.82	-109,942	139,962,835
2021-04-15	2021-04-15	4	HARP	Harpoon Therapeutics, Inc. Common Stock	S - Sale	X	-8,696	7,067,244	-0.12	20.49	-178,181	144,807,830
2021-04-15	2021-04-14	4	HARP	Harpoon Therapeutics, Inc. Common Stock	S - Sale	X	-12,806	7,075,940	-0.18	20.83	-266,749	147,391,830
2021-04-15	2021-04-14	4	HARP	Harpoon Therapeutics, Inc. Common Stock	S - Sale	X	-1,000	7,088,746	-0.01	20.06	-20,060	142,200,245
2021-04-15	2021-04-13	4	HARP	Harpoon Therapeutics, Inc. Common Stock	S - Sale	X	-2,362	7,089,746	-0.03	20.08	-47,429	142,362,100
2021-04-15	2021-04-13	4	HARP	Harpoon Therapeutics, Inc. Common Stock	S - Sale	X	-13,692	7,092,108	-0.19	19.35	-264,940	137,232,290
2021-04-13	2021-04-12	4	HARP	Harpoon Therapeutics, Inc. Common Stock	S - Sale	X	-400	7,105,800	-0.01	22.68	-9,072	161,159,544
2021-04-13	2021-04-12	4	HARP	Harpoon Therapeutics, Inc. Common Stock	S - Sale	X	-6,700	7,106,200	-0.09	21.52	-144,184	152,925,424
2021-04-13	2021-04-12	4	HARP	Harpoon Therapeutics, Inc. Common Stock	S - Sale	X	-13,528	7,112,900	-0.19	20.72	-280,300	147,379,288
2021-04-13	2021-04-09	4	HARP	Harpoon Therapeutics, Inc. Common Stock	S - Sale	X	-10,300	7,126,428	-0.14	23.67	-243,801	168,682,551
2021-04-13	2021-04-09	4	ITOS	iTeos Therapeutics, Inc. Common Stock	S - Sale	X	-200	6,004,368	0.00	29.99	-5,998	180,070,996
2021-04-09	2021-04-08	4	ITOS	iTeos Therapeutics, Inc. Common Stock	S - Sale	X	-414	6,004,568	-0.01	31.01	-12,838	186,201,654
2021-04-09	2021-04-08	4	ITOS	iTeos Therapeutics, Inc. Common Stock	S - Sale	X	-31,890	6,004,982	-0.53	30.51	-972,964	183,212,001
2021-04-09	2021-04-07	4	ITOS	iTeos Therapeutics, Inc. Common Stock	J - Other		-15,670	6,036,872	-0.26
2021-04-09	2021-04-07	4	ITOS	iTeos Therapeutics, Inc. Common Stock	S - Sale	X	-1,300	6,052,542	-0.02	33.84	-43,992	204,818,021
2021-04-09	2021-04-07	4	ITOS	iTeos Therapeutics, Inc. Common Stock	S - Sale	X	-3,083	6,053,842	-0.05	32.84	-101,246	198,808,171
2021-04-09	2021-04-07	4	ITOS	iTeos Therapeutics, Inc. Common Stock	S - Sale	X	-5,295	6,056,925	-0.09	32.07	-169,811	194,245,585
2021-03-15	2021-03-15	4	RPTX	Repare Therapeutics Inc. Common Shares	J - Other		24,271	4,672,838	0.52
2021-03-15	2021-03-12	4	RPTX	Repare Therapeutics Inc. Common Shares	S - Sale		-695,000	4,697,109	-12.89	28.18	-19,585,100	132,364,532
2021-02-12	2021-02-10	4	HARP	Harpoon Therapeutics, Inc. Common Stock	S - Sale	X	-183,051	3,238,306	-5.35	20.00	-3,661,020	64,766,120
2021-02-09	2021-02-09	4	HARP	Harpoon Therapeutics, Inc. Common Stock	S - Sale	X	-9,400	3,421,357	-0.27	20.25	-190,350	69,282,479
2021-02-09	2021-02-08	4	HARP	Harpoon Therapeutics, Inc. Common Stock	S - Sale	X	-72,128	3,430,757	-2.06	20.04	-1,445,445	68,752,370
2021-02-09	2021-02-05	4	HARP	Harpoon Therapeutics, Inc. Common Stock	S - Sale	X	-10,172	3,502,885	-0.29	20.01	-203,542	70,092,729
2021-02-04	2021-02-04	4	HARP	Harpoon Therapeutics, Inc. Common Stock	S - Sale	X	-29,730	3,513,057	-0.84	20.37	-605,600	71,560,971
2021-02-04	2021-02-03	4	HARP	Harpoon Therapeutics, Inc. Common Stock	S - Sale	X	-41,922	3,542,787	-1.17	20.21	-847,244	71,599,725
2021-02-04	2021-02-02	4	HARP	Harpoon Therapeutics, Inc. Common Stock	S - Sale	X	-48,421	3,584,709	-1.33	20.13	-974,715	72,160,192
2021-01-27	2021-01-27	4	HARP	Harpoon Therapeutics, Inc. Common Stock	S - Sale	X	-706,825	3,633,130	-16.29	20.00	-14,136,500	72,662,600
2021-01-27	2021-01-26	4	HARP	Harpoon Therapeutics, Inc. Common Stock	S - Sale	X	-1,363	4,339,955	-0.03	21.08	-28,732	91,486,251
2021-01-27	2021-01-25	4	HARP	Harpoon Therapeutics, Inc. Common Stock	S - Sale	X	-13,006	4,341,318	-0.30	21.23	-276,117	92,166,181
2021-01-22	2021-01-22	4	HARP	Harpoon Therapeutics, Inc. Common Stock	S - Sale	X	-24,695	4,354,324	-0.56	21.72	-536,375	94,575,917
2021-01-22	2021-01-21	4	HARP	Harpoon Therapeutics, Inc. Common Stock	S - Sale	X	-200	4,379,019	0.00	23.77	-4,754	104,089,282
2021-01-22	2021-01-21	4	HARP	Harpoon Therapeutics, Inc. Common Stock	S - Sale	X	-4,887	4,379,219	-0.11	22.61	-110,495	99,014,142
2021-01-22	2021-01-21	4	HARP	Harpoon Therapeutics, Inc. Common Stock	S - Sale	X	-20,979	4,384,106	-0.48	22.11	-463,846	96,932,584
2021-01-22	2021-01-20	4	HARP	Harpoon Therapeutics, Inc. Common Stock	J - Other	X	-101,646	4,405,085	-2.26
2021-01-22	2021-01-20	4	HARP	Harpoon Therapeutics, Inc. Common Stock	S - Sale	X	-2,000	4,506,731	-0.04	24.71	-49,420	111,361,323
2021-01-22	2021-01-20	4	HARP	Harpoon Therapeutics, Inc. Common Stock	S - Sale	X	-15,694	4,508,731	-0.35	23.95	-375,871	107,984,107
2021-01-14	2021-01-12	4	CGEM	Cullinan Management, Inc. Series C Convertible Preferred Stock	C - Conversion		-649,030	0	-100.00
2021-01-14	2021-01-12	4	CGEM	Cullinan Management, Inc. Series B Convertible Preferred Stock	C - Conversion		-2,276,692	0	-100.00
2021-01-14	2021-01-12	4	CGEM	Cullinan Management, Inc. Series A Convertible Preferred Stock	C - Conversion		-3,551,640	0	-100.00
2021-01-14	2021-01-12	4	CGEM	Cullinan Management, Inc. Series Seed Convertible Preferred Stock	C - Conversion		-1,136,525	0	-100.00
2021-01-14	2021-01-12	4	CGEM	Cullinan Management, Inc. Common Stock	P - Purchase		300,000	7,913,887	3.94	21.00	6,300,000	166,191,627
2021-01-14	2021-01-12	4	CGEM	Cullinan Management, Inc. Common Stock	C - Conversion		649,030	7,613,887	9.32
2021-01-14	2021-01-12	4	CGEM	Cullinan Management, Inc. Common Stock	C - Conversion		2,276,692	6,964,857	48.56
2021-01-14	2021-01-12	4	CGEM	Cullinan Management, Inc. Common Stock	C - Conversion		3,551,640	4,688,165	312.50
2021-01-14	2021-01-12	4	CGEM	Cullinan Management, Inc. Common Stock	C - Conversion		1,136,525	1,136,525
2021-01-14	2021-01-07	4	CGEM	Cullinan Management, Inc. Stock Option (Right to Buy)	J - Other		88,824	88,824
2021-01-14	2021-01-07	4	CGEM	Cullinan Management, Inc. Stock Option (Right to Buy)	J - Other		262,114	262,114
2021-01-14	2021-01-07	4	CGEM	Cullinan Management, Inc. Series C Convertible Preferred Stock	J - Other		649,030	649,030
2021-01-14	2021-01-07	4	CGEM	Cullinan Management, Inc. Series B Convertible Preferred Stock	J - Other		2,276,692	2,276,692
2021-01-14	2021-01-07	4	CGEM	Cullinan Management, Inc. Series A Convertible Preferred Stock	J - Other		3,551,640	3,551,640
2021-01-14	2021-01-07	4	CGEM	Cullinan Management, Inc. Series Seed Convertible Preferred Stock	J - Other		1,136,525	1,136,525
2021-01-14	2021-01-07	4	CGEM	Cullinan Management, Inc. Common Stock	J - Other		281,268	281,268
2021-01-07		3	CGEM	Cullinan Management, Inc. Common Stock				281,268
2020-10-21	2020-07-23	4/A	ITOS	iTeos Therapeutics, Inc. Stock Option (Right to Buy)	A - Award		16,608	0	-100.00
2020-10-08	2020-10-06	4	ONCR	Oncorus, Inc. Series B Preferred Stock	C - Conversion		700,453	0	-100.00
2020-10-08	2020-10-06	4	ONCR	Oncorus, Inc. Series B Preferred Stock	C - Conversion		775,975	0	-100.00
2020-10-08	2020-10-06	4	ONCR	Oncorus, Inc. Series A-1 Preferred Stock	C - Conversion		1,525,348	0	-100.00
2020-10-08	2020-10-06	4	ONCR	Oncorus, Inc. Series A-1 Preferred Stock	C - Conversion		1,783,879	0	-100.00
2020-10-08	2020-10-06	4	ONCR	Oncorus, Inc. Common Stock	P - Purchase		151,224	2,377,025	6.79	15.00	2,268,360	35,655,375
2020-10-08	2020-10-06	4	ONCR	Oncorus, Inc. Common Stock	P - Purchase		173,776	2,849,453	6.49	15.00	2,606,640	42,741,795
2020-10-08	2020-10-06	4	ONCR	Oncorus, Inc. Common Stock	C - Conversion		700,453	2,225,801	45.92
2020-10-08	2020-10-06	4	ONCR	Oncorus, Inc. Common Stock	C - Conversion		775,975	2,675,677	40.85
2020-10-08	2020-10-06	4	ONCR	Oncorus, Inc. Common Stock	C - Conversion		1,525,348	1,525,348
2020-10-08	2020-10-06	4	ONCR	Oncorus, Inc. Common Stock	C - Conversion		1,783,879	1,899,702	1,540.18
2020-10-01		3	ONCR	Oncorus, Inc. Common Stock				115,823
2020-09-23	2020-09-21	4	DYN	Dyne Therapeutics, Inc. Series B Preferred Stock	C - Conversion		-26,176	0	-100.00
2020-09-23	2020-09-21	4	DYN	Dyne Therapeutics, Inc. Series B Preferred Stock	C - Conversion		-70,492	0	-100.00
2020-09-23	2020-09-21	4	DYN	Dyne Therapeutics, Inc. Series B Preferred Stock	C - Conversion		-1,326,313	0	-100.00
2020-09-23	2020-09-21	4	DYN	Dyne Therapeutics, Inc. Series A Preferred Stock	C - Conversion		-275,932	0	-100.00
2020-09-23	2020-09-21	4	DYN	Dyne Therapeutics, Inc. Series A Preferred Stock	C - Conversion		-743,076	0	-100.00
2020-09-23	2020-09-21	4	DYN	Dyne Therapeutics, Inc. Series A Preferred Stock	C - Conversion		-13,980,992	0	-100.00
2020-09-23	2020-09-21	4	DYN	Dyne Therapeutics, Inc. Common Stock	C - Conversion		91,081	91,081
2020-09-23	2020-09-21	4	DYN	Dyne Therapeutics, Inc. Common Stock	C - Conversion		245,279	245,279
2020-09-23	2020-09-21	4	DYN	Dyne Therapeutics, Inc. Common Stock	C - Conversion		4,614,943	4,614,943
2020-08-05	2020-08-03	4	ALVR	Allovir, Inc. Series A-2 Convertible Preferred Stock	C - Conversion		-20,000,000	0	-100.00
2020-08-05	2020-08-03	4	ALVR	Allovir, Inc. Common Stock	C - Conversion		13,420,970	13,420,970
2020-07-31	2020-07-29	4	ALVR	Allovir, Inc. Stock Option (Right to Buy)	A - Award		22,500	22,500
2020-07-30	2020-07-28	4	ITOS	iTeos Therapeutics, Inc. Series B-2 Preferred Stock	C - Conversion		-2,600,628	0	-100.00
2020-07-30	2020-07-28	4	ITOS	iTeos Therapeutics, Inc. Series B-2 Preferred Stock	C - Conversion		-29,440	0	-100.00
2020-07-30	2020-07-28	4	ITOS	iTeos Therapeutics, Inc. Series B-2 Preferred Stock	C - Conversion		-79,281	0	-100.00
2020-07-30	2020-07-28	4	ITOS	iTeos Therapeutics, Inc. Series B-2 Preferred Stock	C - Conversion		-1,491,666	0	-100.00
2020-07-30	2020-07-28	4	ITOS	iTeos Therapeutics, Inc. Series B-2 Preferred Stock	C - Conversion		-81,295	0	-100.00
2020-07-30	2020-07-28	4	ITOS	iTeos Therapeutics, Inc. Series B-2 Preferred Stock	C - Conversion		-157,529	0	-100.00
2020-07-30	2020-07-28	4	ITOS	iTeos Therapeutics, Inc. Series B-2 Preferred Stock	C - Conversion		-2,361,805	0	-100.00
2020-07-30	2020-07-28	4	ITOS	iTeos Therapeutics, Inc. Series B Preferred Stock	C - Conversion		-4,211,330	0	-100.00
2020-07-30	2020-07-28	4	ITOS	iTeos Therapeutics, Inc. Series B Preferred Stock	C - Conversion		-47,674	0	-100.00
2020-07-30	2020-07-28	4	ITOS	iTeos Therapeutics, Inc. Series B Preferred Stock	C - Conversion		-128,384	0	-100.00
2020-07-30	2020-07-28	4	ITOS	iTeos Therapeutics, Inc. Series B Preferred Stock	C - Conversion		-2,415,530	0	-100.00
2020-07-30	2020-07-28	4	ITOS	iTeos Therapeutics, Inc. Series B Preferred Stock	C - Conversion		-131,645	0	-100.00
2020-07-30	2020-07-28	4	ITOS	iTeos Therapeutics, Inc. Series B Preferred Stock	C - Conversion		-255,094	0	-100.00
2020-07-30	2020-07-28	4	ITOS	iTeos Therapeutics, Inc. Series B Preferred Stock	C - Conversion		-3,824,591	0	-100.00
2020-07-30	2020-07-28	4	ITOS	iTeos Therapeutics, Inc. Common Stock	P - Purchase		160,000	2,355,557	7.29	19.00	3,040,000	44,755,583
2020-07-30	2020-07-28	4	ITOS	iTeos Therapeutics, Inc. Common Stock	P - Purchase		1,121	25,974	4.51	19.00	21,299	493,506
2020-07-30	2020-07-28	4	ITOS	iTeos Therapeutics, Inc. Common Stock	P - Purchase		3,020	69,951	4.51	19.00	57,380	1,329,069
2020-07-30	2020-07-28	4	ITOS	iTeos Therapeutics, Inc. Common Stock	P - Purchase		56,814	1,316,139	4.51	19.00	1,079,466	25,006,641
2020-07-30	2020-07-28	4	ITOS	iTeos Therapeutics, Inc. Common Stock	P - Purchase		3,096	71,727	4.51	19.00	58,824	1,362,813
2020-07-30	2020-07-28	4	ITOS	iTeos Therapeutics, Inc. Common Stock	P - Purchase		5,994	138,985	4.51	19.00	113,886	2,640,715
2020-07-30	2020-07-28	4	ITOS	iTeos Therapeutics, Inc. Common Stock	P - Purchase		89,955	2,083,887	4.51	19.00	1,709,145	39,593,853
2020-07-30	2020-07-28	4	ITOS	iTeos Therapeutics, Inc. Common Stock	C - Conversion		797,983	2,195,557	57.10
2020-07-30	2020-07-28	4	ITOS	iTeos Therapeutics, Inc. Common Stock	C - Conversion		9,033	24,853	57.10
2020-07-30	2020-07-28	4	ITOS	iTeos Therapeutics, Inc. Common Stock	C - Conversion		24,326	66,931	57.10
2020-07-30	2020-07-28	4	ITOS	iTeos Therapeutics, Inc. Common Stock	C - Conversion		457,706	1,259,325	57.10
2020-07-30	2020-07-28	4	ITOS	iTeos Therapeutics, Inc. Common Stock	C - Conversion		24,944	68,381	57.43
2020-07-30	2020-07-28	4	ITOS	iTeos Therapeutics, Inc. Common Stock	C - Conversion		48,336	132,991	57.10
2020-07-30	2020-07-28	4	ITOS	iTeos Therapeutics, Inc. Common Stock	C - Conversion		724,702	1,993,932	57.10
2020-07-30	2020-07-28	4	ITOS	iTeos Therapeutics, Inc. Common Stock	C - Conversion		1,397,574	1,397,574
2020-07-30	2020-07-28	4	ITOS	iTeos Therapeutics, Inc. Common Stock	C - Conversion		15,820	15,820
2020-07-30	2020-07-28	4	ITOS	iTeos Therapeutics, Inc. Common Stock	C - Conversion		42,605	42,605
2020-07-30	2020-07-28	4	ITOS	iTeos Therapeutics, Inc. Common Stock	C - Conversion		801,619	801,619
2020-07-30	2020-07-28	4	ITOS	iTeos Therapeutics, Inc. Common Stock	C - Conversion		43,687	43,687
2020-07-30	2020-07-28	4	ITOS	iTeos Therapeutics, Inc. Common Stock	C - Conversion		84,655	84,655
2020-07-30	2020-07-28	4	ITOS	iTeos Therapeutics, Inc. Common Stock	C - Conversion		1,269,230	1,269,230
2020-07-29		3	ALVR	Allovir, Inc. Common Stock				60,394
2020-07-29		3	ALVR	Allovir, Inc. Common Stock				60,394
2020-07-29		3	ALVR	Allovir, Inc. Common Stock				60,394
2020-07-24	2020-07-23	4	ITOS	iTeos Therapeutics, Inc. Stock Option (Right to Buy)	A - Award		16,608	0	-100.00
2020-06-25	2020-06-23	4	RPTX	Repare Therapeutics Inc. Class B Preferred Shares	C - Conversion		-1,288,948	0	-100.00
2020-06-25	2020-06-23	4	RPTX	Repare Therapeutics Inc. Class A Preferred Shares	C - Conversion		-3,603,161	0	-100.00
2020-06-25	2020-06-23	4	RPTX	Repare Therapeutics Inc. Common Shares	P - Purchase		500,000	5,392,109	10.22	20.00	10,000,000	107,842,180
2020-06-25	2020-06-23	4	RPTX	Repare Therapeutics Inc. Common Shares	C - Conversion		1,288,948	4,892,109	35.77
2020-06-25	2020-06-23	4	RPTX	Repare Therapeutics Inc. Common Shares	C - Conversion		3,603,161	3,603,161
2019-02-21	2019-02-19	4	TCRR	TCR2 THERAPEUTICS INC. Series B Preferred Stock	C - Conversion		-1,750,000	0	-100.00
2019-02-21	2019-02-19	4	TCRR	TCR2 THERAPEUTICS INC. Series B Preferred Stock	C - Conversion		-217,500	0	-100.00
2019-02-21	2019-02-19	4	TCRR	TCR2 THERAPEUTICS INC. Series B Preferred Stock	C - Conversion		-1,586,623	0	-100.00
2019-02-21	2019-02-19	4	TCRR	TCR2 THERAPEUTICS INC. Series B Preferred Stock	C - Conversion		-105,825	0	-100.00
2019-02-21	2019-02-19	4	TCRR	TCR2 THERAPEUTICS INC. Series B Preferred Stock	C - Conversion		-32,500	0	-100.00
2019-02-21	2019-02-19	4	TCRR	TCR2 THERAPEUTICS INC. Series B Preferred Stock	C - Conversion		-57,552	0	-100.00
2019-02-21	2019-02-19	4	TCRR	TCR2 THERAPEUTICS INC. Series A Preferred Stock	C - Conversion		-15,000,000	0	-100.00
2019-02-21	2019-02-19	4	TCRR	TCR2 THERAPEUTICS INC. Series A Preferred Stock	C - Conversion		-2,174,998	0	-100.00
2019-02-21	2019-02-19	4	TCRR	TCR2 THERAPEUTICS INC. Series A Preferred Stock	C - Conversion		-13,599,621	0	-100.00
2019-02-21	2019-02-19	4	TCRR	TCR2 THERAPEUTICS INC. Series A Preferred Stock	C - Conversion		-907,073	0	-100.00
2019-02-21	2019-02-19	4	TCRR	TCR2 THERAPEUTICS INC. Series A Preferred Stock	C - Conversion		-325,002	0	-100.00
2019-02-21	2019-02-19	4	TCRR	TCR2 THERAPEUTICS INC. Series A Preferred Stock	C - Conversion		-493,306	0	-100.00
2019-02-21	2019-02-19	4	TCRR	TCR2 THERAPEUTICS INC. Common Stock	P - Purchase		1,373,333	1,569,235	701.03	15.00	20,599,995	23,538,525
2019-02-21	2019-02-19	4	TCRR	TCR2 THERAPEUTICS INC. Common Stock	C - Conversion		282,540	2,704,315	11.67
2019-02-21	2019-02-19	4	TCRR	TCR2 THERAPEUTICS INC. Common Stock	C - Conversion		35,115	386,270	10.00
2019-02-21	2019-02-19	4	TCRR	TCR2 THERAPEUTICS INC. Common Stock	C - Conversion		256,163	2,451,844	11.67
2019-02-21	2019-02-19	4	TCRR	TCR2 THERAPEUTICS INC. Common Stock	C - Conversion		17,085	163,532	11.67
2019-02-21	2019-02-19	4	TCRR	TCR2 THERAPEUTICS INC. Common Stock	C - Conversion		5,247	57,716	10.00
2019-02-21	2019-02-19	4	TCRR	TCR2 THERAPEUTICS INC. Common Stock	C - Conversion		9,291	88,935	11.67
2019-02-21	2019-02-19	4	TCRR	TCR2 THERAPEUTICS INC. Common Stock	C - Conversion		2,421,775	2,421,775
2019-02-21	2019-02-19	4	TCRR	TCR2 THERAPEUTICS INC. Common Stock	C - Conversion		351,155	351,155
2019-02-21	2019-02-19	4	TCRR	TCR2 THERAPEUTICS INC. Common Stock	C - Conversion		2,195,681	2,195,681
2019-02-21	2019-02-19	4	TCRR	TCR2 THERAPEUTICS INC. Common Stock	C - Conversion		146,447	146,447
2019-02-21	2019-02-19	4	TCRR	TCR2 THERAPEUTICS INC. Common Stock	C - Conversion		52,469	52,469
2019-02-21	2019-02-19	4	TCRR	TCR2 THERAPEUTICS INC. Common Stock	C - Conversion		79,644	79,644
2019-02-14	2019-02-12	4	HARP	Harpoon Therapeutics, Inc. Common Stock Warrant (Right to Buy)	X - Other		-101,675	0	-100.00
2019-02-14	2019-02-12	4	HARP	Harpoon Therapeutics, Inc. Common Stock Warrant (Right to Buy)	X - Other		-152,514	0	-100.00
2019-02-14	2019-02-12	4	HARP	Harpoon Therapeutics, Inc. Common Stock Warrant (Right to Buy)	X - Other		-50,837	0	-100.00
2019-02-14	2019-02-12	4	HARP	Harpoon Therapeutics, Inc. Common Stock Warrant (Right to Buy)	X - Other		-171,579	0	-100.00
2019-02-14	2019-02-12	4	HARP	Harpoon Therapeutics, Inc. Common Stock Warrant (Right to Buy)	X - Other		-57,192	0	-100.00
2019-02-14	2019-02-12	4	HARP	Harpoon Therapeutics, Inc. Common Stock Warrant (Right to Buy)	X - Other		-25,418	0	-100.00
2019-02-14	2019-02-12	4	HARP	Harpoon Therapeutics, Inc. Series C Preferred Stock	C - Conversion		-835,705	0	-100.00
2019-02-14	2019-02-12	4	HARP	Harpoon Therapeutics, Inc. Series B Preferred Stock	C - Conversion		-3,157,506	0	-100.00
2019-02-14	2019-02-12	4	HARP	Harpoon Therapeutics, Inc. Series A Preferred Stock	C - Conversion		-3,050,329	0	-100.00
2019-02-14	2019-02-12	4	HARP	Harpoon Therapeutics, Inc. Common Stock	P - Purchase		500,000	8,422,847	6.31	14.00	7,000,000	117,919,858
2019-02-14	2019-02-12	4	HARP	Harpoon Therapeutics, Inc. Common Stock	S - Sale		-1,971	7,922,847	-0.02	14.00	-27,594	110,919,858
2019-02-14	2019-02-12	4	HARP	Harpoon Therapeutics, Inc. Common Stock	X - Other		559,215	7,924,818	7.59	0.05	27,513	389,901
2019-02-14	2019-02-12	4	HARP	Harpoon Therapeutics, Inc. Common Stock	C - Conversion		835,705	7,365,603	12.80
2019-02-14	2019-02-12	4	HARP	Harpoon Therapeutics, Inc. Common Stock	C - Conversion		3,157,506	6,529,898	93.63
2019-02-14	2019-02-12	4	HARP	Harpoon Therapeutics, Inc. Common Stock	C - Conversion		3,050,329	3,372,392	947.12
2019-02-13		3	TCRR	TCR2 THERAPEUTICS INC. Common Stock				391,804
2019-02-13		3	TCRR	TCR2 THERAPEUTICS INC. Common Stock				391,804
2019-02-13		3	TCRR	TCR2 THERAPEUTICS INC. Common Stock				391,804
2019-02-07		3	HARP	Harpoon Therapeutics, Inc. Common Stock				644,126
2019-02-07		3	HARP	Harpoon Therapeutics, Inc. Common Stock				644,126
2019-02-07		3	HARP	Harpoon Therapeutics, Inc. Common Stock				644,126
2017-10-11	2017-10-10	4	RYTM	RHYTHM PHARMACEUTICALS, INC. Series A-1 Junior Preferred Stock	C - Conversion		-15,887,703	0	-100.00
2017-10-11	2017-10-10	4	RYTM	RHYTHM PHARMACEUTICALS, INC. Series A Preferred Stock	C - Conversion		-7,651,831	0	-100.00
2017-10-11	2017-10-10	4	RYTM	RHYTHM PHARMACEUTICALS, INC. Common Stock	P - Purchase		100,000	2,696,392	3.85	17.00	1,700,000	45,838,664
2017-10-11	2017-10-10	4	RYTM	RHYTHM PHARMACEUTICALS, INC. Common Stock	C - Conversion		2,567,014	2,596,392	8,737.88
2017-10-04		3	RYTM	RHYTHM PHARMACEUTICALS, INC. Common Stock				58,756
2017-10-04		3	RYTM	RHYTHM PHARMACEUTICALS, INC. Common Stock				58,756
2017-10-04		3	RYTM	RHYTHM PHARMACEUTICALS, INC. Common Stock				58,756
2017-10-04		3	RYTM	RHYTHM PHARMACEUTICALS, INC. Common Stock				58,756
2017-10-04		3	RYTM	RHYTHM PHARMACEUTICALS, INC. Common Stock				58,756
2017-10-04		3	RYTM	RHYTHM PHARMACEUTICALS, INC. Common Stock				58,756
2017-10-04		3	RYTM	RHYTHM PHARMACEUTICALS, INC. Common Stock				58,756
2017-02-22	2017-02-17	4	RDUS	Radius Health, Inc. Stock Option (Right to Buy)	A - Award		27,500	27,500
2016-09-29	2016-09-27	4	RDUS	Radius Health, Inc. Common Stock	J - Other		-1,943,751	3,887,502	-33.33
2016-06-13	2016-06-09	4	CHMA	CHIASMA, INC Stock Option (Right to Buy)	A - Award		10,000	10,000
2016-06-02	2016-05-24	4	RDUS	Radius Health, Inc. Stock Option (Right to Buy)	A - Award		27,500	27,500
2016-03-09	2016-03-08	4	SNDX	Syndax Pharmaceuticals Inc Series C-1 Preferred Stock	C - Conversion		-312,085	0	-100.00
2016-03-09	2016-03-08	4	SNDX	Syndax Pharmaceuticals Inc Series B-1 Preferred Stock	C - Conversion		-718,396	0	-100.00
2016-03-09	2016-03-08	4	SNDX	Syndax Pharmaceuticals Inc Series A-1 Preferred Stock	C - Conversion		-1,138,210	0	-100.00
2016-03-09	2016-03-08	4	SNDX	Syndax Pharmaceuticals Inc Common Stock	C - Conversion		312,085	2,168,691	16.81
2016-03-09	2016-03-08	4	SNDX	Syndax Pharmaceuticals Inc Common Stock	C - Conversion		718,396	1,856,606	63.12
2016-03-09	2016-03-08	4	SNDX	Syndax Pharmaceuticals Inc Common Stock	C - Conversion		1,138,210	1,138,210
2016-02-12	2016-02-10	4	RDUS	Radius Health, Inc. Stock Option (Right to Buy)	A - Award		27,500	27,500
2015-10-20	2015-10-20	4	CERC	Cerecor Inc. Series B Convertible Preferred Stock	C - Conversion		-16,672,224	0	-100.00
2015-10-20	2015-10-20	4	CERC	Cerecor Inc. Common Stock	C - Conversion		595,436	595,436
2015-07-21	2015-07-21	4	CHMA	CHIASMA, INC Series E Preferred Stock	C - Conversion		-13,000,000	0	-100.00
2015-07-21	2015-07-21	4	CHMA	CHIASMA, INC Series D' Preferred Stock	C - Conversion		-16,066,669	0	-100.00
2015-07-21	2015-07-21	4	CHMA	CHIASMA, INC Series C' Preferred Stock	C - Conversion		-22,721,988	0	-100.00
2015-07-21	2015-07-21	4	CHMA	CHIASMA, INC Series B-1' Preferred Stock	C - Conversion		-95,225	0	-100.00
2015-07-21	2015-07-21	4	CHMA	CHIASMA, INC Common Stock	C - Conversion		1,423,566	5,681,544	33.43
2015-07-21	2015-07-21	4	CHMA	CHIASMA, INC Common Stock	C - Conversion		1,759,381	4,257,978	70.41
2015-07-21	2015-07-21	4	CHMA	CHIASMA, INC Common Stock	C - Conversion		2,488,171	2,498,597	23,865.06
2015-07-21	2015-07-21	4	CHMA	CHIASMA, INC Common Stock	C - Conversion		10,426	10,426
2015-05-26	2015-05-07	4	RDUS	Radius Health, Inc. Stock Option (Right to Buy)	A - Award		15,000	15,000
2014-12-19	2014-12-17	4	RDUS	Radius Health, Inc. Stock Option (Right to Buy)	A - Award		30,000	30,000
2014-06-10	2014-06-06	4	RDUS	Radius Health, Inc. Series A-2 Convertible Preferred Stock	C - Conversion		-184,242	0	-100.00
2014-06-10	2014-06-06	4	RDUS	Radius Health, Inc. Series A-1 Convertible Preferred Stock	C - Conversion		-114,537	0	-100.00
2014-06-10	2014-06-06	4	RDUS	Radius Health, Inc. Series B Convertible Preferred Stock	C - Conversion		-71,638	0	-100.00
2014-06-10	2014-06-06	4	RDUS	Radius Health, Inc. Series A-3 Convertible Preferred Stock	C - Conversion		-859	0	-100.00
2014-06-10	2014-06-06	4	RDUS	Radius Health, Inc. Series A-2 Convertible Preferred Stock	C - Conversion		-3,511	0	-100.00
2014-06-10	2014-06-06	4	RDUS	Radius Health, Inc. Series A-1 Convertible Preferred Stock	C - Conversion		-4,346	0	-100.00
2014-06-10	2014-06-06	4	RDUS	Radius Health, Inc. Series B Convertible Preferred Stock	C - Conversion		-1,468	0	-100.00
2014-06-10	2014-06-06	4	RDUS	Radius Health, Inc. Series A-3 Convertible Preferred Stock	C - Conversion		-1,340	0	-100.00
2014-06-10	2014-06-06	4	RDUS	Radius Health, Inc. Series A-2 Convertible Preferred Stock	C - Conversion		-5,477	0	-100.00
2014-06-10	2014-06-06	4	RDUS	Radius Health, Inc. Series A-1 Convertible Preferred Stock	C - Conversion		-6,779	0	-100.00
2014-06-10	2014-06-06	4	RDUS	Radius Health, Inc. Series B Convertible Preferred Stock	C - Conversion		-2,291	0	-100.00
2014-06-10	2014-06-06	4	RDUS	Radius Health, Inc. Series A-3 Convertible Preferred Stock	C - Conversion		-3,752	0	-100.00
2014-06-10	2014-06-06	4	RDUS	Radius Health, Inc. Series A-2 Convertible Preferred Stock	C - Conversion		-15,327	0	-100.00
2014-06-10	2014-06-06	4	RDUS	Radius Health, Inc. Series A-1 Convertible Preferred Stock	C - Conversion		-18,975	0	-100.00
2014-06-10	2014-06-06	4	RDUS	Radius Health, Inc. Series B Convertible Preferred Stock	C - Conversion		-6,414	0	-100.00
2014-06-10	2014-06-06	4	RDUS	Radius Health, Inc. Series A-3 Convertible Preferred Stock	C - Conversion		-44,395	0	-100.00
2014-06-10	2014-06-06	4	RDUS	Radius Health, Inc. Series A-2 Convertible Preferred Stock	C - Conversion		-181,364	0	-100.00
2014-06-10	2014-06-06	4	RDUS	Radius Health, Inc. Series A-1 Convertible Preferred Stock	C - Conversion		-224,528	0	-100.00
2014-06-10	2014-06-06	4	RDUS	Radius Health, Inc. Series B Convertible Preferred Stock	C - Conversion		-75,899	0	-100.00
2014-06-10	2014-06-06	4	RDUS	Radius Health, Inc. Series A-3 Convertible Preferred Stock	C - Conversion		-2,985	0	-100.00
2014-06-10	2014-06-06	4	RDUS	Radius Health, Inc. Series A-2 Convertible Preferred Stock	C - Conversion		-12,194	0	-100.00
2014-06-10	2014-06-06	4	RDUS	Radius Health, Inc. Series A-1 Convertible Preferred Stock	C - Conversion		-15,096	0	-100.00
2014-06-10	2014-06-06	4	RDUS	Radius Health, Inc. Series B Convertible Preferred Stock	C - Conversion		-5,103	0	-100.00
2014-06-10	2014-06-06	4	RDUS	Radius Health, Inc. Common Stock	C - Conversion		2,141,547	2,141,547
2014-06-10	2014-06-06	4	RDUS	Radius Health, Inc. Common Stock	C - Conversion		59,445	59,445
2014-06-10	2014-06-06	4	RDUS	Radius Health, Inc. Common Stock	C - Conversion		92,734	92,734
2014-06-10	2014-06-06	4	RDUS	Radius Health, Inc. Common Stock	C - Conversion		259,567	259,567
2014-06-10	2014-06-06	4	RDUS	Radius Health, Inc. Common Stock	C - Conversion		3,071,454	3,071,454
2014-06-10	2014-06-06	4	RDUS	Radius Health, Inc. Common Stock	C - Conversion		206,506	206,506
2014-04-23	2014-04-22	4	TRIV	TriVascular Technologies, Inc. Warrant to Purchase Common Stock (Right to Buy)	C - Conversion		37,369	37,369
2014-04-23	2014-04-22	4	TRIV	TriVascular Technologies, Inc. Warrant to Purchase Series D Preferred Stock (Right to Buy)	C - Conversion		-1,516,122	0	-100.00
2014-04-23	2014-04-22	4	TRIV	TriVascular Technologies, Inc. Series E Convertible Preferred Stock	C - Conversion		-10,266,940	0	-100.00
2014-04-23	2014-04-22	4	TRIV	TriVascular Technologies, Inc. Series D Convertible Preferred Stock	C - Conversion		-15,400,411	0	-100.00
2014-04-23	2014-04-22	4	TRIV	TriVascular Technologies, Inc. Series C Convertible Preferred Stock	C - Conversion		-2,947,605	0	-100.00
2014-04-23	2014-04-22	4	TRIV	TriVascular Technologies, Inc. Series B Convertible Preferred Stock	C - Conversion		-6,000,000	0	-100.00
2014-04-23	2014-04-22	4	TRIV	TriVascular Technologies, Inc. Series A Convertible Preferred Stock	C - Conversion		-20,757,635	0	-100.00
2014-04-23	2014-04-22	4	TRIV	TriVascular Technologies, Inc. Common Stock	C - Conversion		253,066	1,776,692	16.61
2014-04-23	2014-04-22	4	TRIV	TriVascular Technologies, Inc. Common Stock	C - Conversion		379,599	1,523,626	33.18
2014-04-23	2014-04-22	4	TRIV	TriVascular Technologies, Inc. Common Stock	C - Conversion		114,942	1,144,027	11.17
2014-04-23	2014-04-22	4	TRIV	TriVascular Technologies, Inc. Common Stock	C - Conversion		230,756	1,029,085	28.90
2014-04-23	2014-04-22	4	TRIV	TriVascular Technologies, Inc. Common Stock	C - Conversion		798,329	798,329
2014-03-12	2014-03-10	4	PETX	ARATANA THERAPEUTICS, INC. Common Stock	S - Sale		-600,000	2,751,048	-17.90	20.02	-12,012,000	55,075,981
2014-03-11	2014-03-07	4	PETX	ARATANA THERAPEUTICS, INC. Common Stock	S - Sale		-26,713	0	-100.00	20.16	-538,534
2014-03-05	2014-03-03	4	PETX	ARATANA THERAPEUTICS, INC. Common Stock	J - Other		37,117	37,117
2014-03-05	2014-03-03	4	PETX	ARATANA THERAPEUTICS, INC. Common Stock	J - Other		12,247	12,393	8,388.36
2014-03-05	2014-03-03	4	PETX	ARATANA THERAPEUTICS, INC. Common Stock	J - Other		15,310	17,937	582.79
2014-03-05	2014-03-03	4	PETX	ARATANA THERAPEUTICS, INC. Common Stock	J - Other		20,876	22,767	1,103.97
2014-03-05	2014-03-03	4	PETX	ARATANA THERAPEUTICS, INC. Common Stock	J - Other		20,876	22,767	1,103.97
2014-03-05	2014-03-03	4	PETX	ARATANA THERAPEUTICS, INC. Common Stock	J - Other		20,876	38,386	119.22
2014-03-05	2014-03-03	4	PETX	ARATANA THERAPEUTICS, INC. Common Stock	J - Other		-1,000,000	3,351,048	-22.98
2014-02-11	2014-02-10	4	EPZM	Epizyme, Inc. Common Stock	S - Sale		-466,666	2,413,819	-16.20	29.25	-13,649,980	70,604,206
2013-08-01	2013-07-30	4	CNAT	Conatus Pharmaceuticals Inc Warrant to Purchase Common Stock (Right to Buy)	C - Conversion		32,220	32,220
2013-08-01	2013-07-30	4	CNAT	Conatus Pharmaceuticals Inc Warrant to Purchase Series B Preferred Stock (Right to Buy)	C - Conversion		-265,837	0	-100.00
2013-08-01	2013-07-30	4	CNAT	Conatus Pharmaceuticals Inc Series B Convertible Preferred Stock	C - Conversion		-8,333,334	0	-100.00
2013-08-01	2013-07-30	4	CNAT	Conatus Pharmaceuticals Inc Common Stock	P - Purchase		165,265	1,192,080	16.09	11.00	1,817,915	13,112,880
2013-08-01	2013-07-30	4	CNAT	Conatus Pharmaceuticals Inc Common Stock	J - Other		16,716	1,026,815	1.65	11.00	183,876	11,294,965
2013-08-01	2013-07-30	4	CNAT	Conatus Pharmaceuticals Inc Common Stock	C - Conversion		1,010,099	1,010,099
2013-07-02	2013-07-02	4	PETX	ARATANA THERAPEUTICS, INC. Series C Preferred Stock	C - Conversion		-375,000	0	-100.00
2013-07-02	2013-07-02	4	PETX	ARATANA THERAPEUTICS, INC. Series B Preferred Stock	C - Conversion		-1,333,333	0	-100.00
2013-07-02	2013-07-02	4	PETX	ARATANA THERAPEUTICS, INC. Series A Preferred Stock	C - Conversion		-4,000,000	0	-100.00
2013-07-02	2013-07-02	4	PETX	ARATANA THERAPEUTICS, INC. Common Stock	P - Purchase		500,000	4,351,050	12.98	6.00	3,000,000	26,106,300
2013-07-02	2013-07-02	4	PETX	ARATANA THERAPEUTICS, INC. Common Stock	C - Conversion		225,631	3,851,050	6.22
2013-07-02	2013-07-02	4	PETX	ARATANA THERAPEUTICS, INC. Common Stock	C - Conversion		802,246	3,625,419	28.42
2013-07-02	2013-07-02	4	PETX	ARATANA THERAPEUTICS, INC. Common Stock	C - Conversion		2,406,739	2,823,173	577.94
2013-06-26		3	PETX	ARATANA THERAPEUTICS, INC. Common Stock				180,505
2013-06-06	2013-06-05	4	EPZM	Epizyme, Inc. Series B Preferred Stock	C - Conversion		-1,176,472	0	-100.00
2013-06-06	2013-06-05	4	EPZM	Epizyme, Inc. Series A Preferred Stock	C - Conversion		-6,930,000	0	-100.00
2013-06-06	2013-06-05	4	EPZM	Epizyme, Inc. Common Stock	C - Conversion		392,156	2,880,485	15.76
2013-06-06	2013-06-05	4	EPZM	Epizyme, Inc. Common Stock	C - Conversion		2,309,998	2,488,329	1,295.34
2013-05-30		3	EPZM	Epizyme, Inc. Common Stock				178,331
2013-04-25	2013-04-23	4	NONE	Radius Health, Inc. Common Stock Warrant	A - Award		179,095	179,095
2013-04-25	2013-04-23	4	NONE	Radius Health, Inc. Series B Convertible Preferred Stock	A - Award		71,638	71,638		61.42	4,400,006	4,400,006
2013-04-25	2013-04-23	4	NONE	Radius Health, Inc. Common Stock Warrant	A - Award		3,670	3,670
2013-04-25	2013-04-23	4	NONE	Radius Health, Inc. Series B Convertible Preferred Stock	A - Award		1,468	1,468		61.42	90,165	90,165
2013-04-25	2013-04-23	4	NONE	Radius Health, Inc. Common Stock Warrant	A - Award		5,728	5,728
2013-04-25	2013-04-23	4	NONE	Radius Health, Inc. Series B Convertible Preferred Stock	A - Award		2,291	2,291		61.42	140,713	140,713
2013-04-25	2013-04-23	4	NONE	Radius Health, Inc. Common Stock Warrant	A - Award		16,035	16,035
2013-04-25	2013-04-23	4	NONE	Radius Health, Inc. Series B Convertible Preferred Stock	A - Award		6,414	6,414		61.42	393,948	393,948
2013-04-25	2013-04-23	4	NONE	Radius Health, Inc. Common Stock Warrant	A - Award		189,748	189,748
2013-04-25	2013-04-23	4	NONE	Radius Health, Inc. Series B Convertible Preferred Stock	A - Award		75,899	75,899		61.42	4,661,717	4,661,717
2013-04-25	2013-04-23	4	NONE	Radius Health, Inc. Common Stock Warrant	A - Award		12,758	12,758
2013-04-25	2013-04-23	4	NONE	Radius Health, Inc. Series B Convertible Preferred Stock	A - Award		5,103	5,103		61.42	313,426	313,426
2013-03-13	2013-03-11	4	PCRX	Pacira Pharmaceuticals, Inc. Common Stock	S - Sale		-500,000	2,790,479	-15.20	27.86	-13,930,000	77,742,745
2013-02-07	2013-02-05	4	KBIO	KALOBIOS PHARMACEUTICALS INC Series D Preferred Stock	C - Conversion		-275,539	0	-100.00
2013-02-07	2013-02-05	4	KBIO	KALOBIOS PHARMACEUTICALS INC Series C Preferred Stock	C - Conversion		-337,622	0	-100.00
2013-02-07	2013-02-05	4	KBIO	KALOBIOS PHARMACEUTICALS INC Series B-2 Preferred Stock	C - Conversion		-1,949,879	0	-100.00
2013-02-07	2013-02-05	4	KBIO	KALOBIOS PHARMACEUTICALS INC Common Stock	C - Conversion		313,527	2,632,928	13.52
2013-02-07	2013-02-05	4	KBIO	KALOBIOS PHARMACEUTICALS INC Common Stock	C - Conversion		369,522	2,319,401	18.95
2013-02-07	2013-02-05	4	KBIO	KALOBIOS PHARMACEUTICALS INC Common Stock	C - Conversion		1,949,879	1,949,879
2012-07-10	2012-07-09	4	SOMX	Somaxon Pharmaceuticals, Inc. Common Stock	S - Sale		-1,624,574	1,275,886	-56.01	0.31	-498,744	391,697
2012-07-10	2012-07-06	4	SOMX	Somaxon Pharmaceuticals, Inc. Common Stock	S - Sale		-671,217	2,900,460	-18.79	0.29	-195,324	844,034
2012-07-05	2012-07-03	4	SOMX	Somaxon Pharmaceuticals, Inc. Common Stock	S - Sale		-98,210	3,571,677	-2.68	0.29	-28,481	1,035,786
2012-07-05	2012-07-02	4	SOMX	Somaxon Pharmaceuticals, Inc. Common Stock	S - Sale		-80,348	3,669,887	-2.14	0.29	-23,301	1,064,267
2012-07-02	2012-06-28	4	SOMX	Somaxon Pharmaceuticals, Inc. Common Stock	S - Sale		-19,500	3,750,235	-0.52	0.29	-5,655	1,087,568
2012-06-21	2012-06-19	4	SOMX	Somaxon Pharmaceuticals, Inc. Common Stock	S - Sale		-12,000	3,759,735	-0.32	0.29	-3,480	1,090,323
2012-06-19	2012-06-15	4	SOMX	Somaxon Pharmaceuticals, Inc. Common Stock	S - Sale		-1,450	3,781,735	-0.04	0.29	-420	1,096,703
2012-06-07	2012-06-06	4	SOMX	Somaxon Pharmaceuticals, Inc. Common Stock	S - Sale		-8,400	3,783,185	-0.22	0.29	-2,436	1,097,124
2012-06-07	2012-06-05	4	SOMX	Somaxon Pharmaceuticals, Inc. Common Stock	S - Sale		-29,555	3,791,585	-0.77	0.29	-8,571	1,099,560
2012-06-04	2012-05-31	4	SOMX	Somaxon Pharmaceuticals, Inc. Common Stock	S - Sale		-29,850	3,821,140	-0.78	0.30	-8,955	1,146,342
2012-06-04	2012-05-30	4	SOMX	Somaxon Pharmaceuticals, Inc. Common Stock	S - Sale		-51,007	3,850,990	-1.31	0.30	-15,302	1,155,297
2012-06-04	2012-05-29	4	SOMX	Somaxon Pharmaceuticals, Inc. Common Stock	S - Sale		-15,300	3,901,997	-0.39	0.30	-4,622	1,178,793
2012-06-04	2012-05-25	4	SOMX	Somaxon Pharmaceuticals, Inc. Common Stock	S - Sale		-293,015	3,917,297	-6.96	0.30	-87,904	1,175,189
2012-06-04	2012-05-23	4	SOMX	Somaxon Pharmaceuticals, Inc. Common Stock	S - Sale		-135,250	4,210,312	-3.11	0.30	-40,629	1,264,778
2012-06-04	2012-05-22	4	SOMX	Somaxon Pharmaceuticals, Inc. Common Stock	S - Sale		-287,000	4,345,562	-6.20	0.30	-86,990	1,317,140
2012-03-08	2012-03-06	4	VSTM	Verastem, Inc. Stock Option (Right to Buy)	A - Award		12,500	12,500
2012-02-03	2012-02-01	4	VSTM	Verastem, Inc. Series C Preferred Stock	C - Conversion		-266,666	0	-100.00
2012-02-03	2012-02-01	4	VSTM	Verastem, Inc. Series B Preferred Stock	C - Conversion		-2,500,000	0	-100.00
2012-02-03	2012-02-01	4	VSTM	Verastem, Inc. Series A Preferred Stock	C - Conversion		-4,000,000	0	-100.00
2012-02-03	2012-02-01	4	VSTM	Verastem, Inc. Common Stock	P - Purchase		3,740	3,740		10.00	37,400	37,400
2012-02-03	2012-02-01	4	VSTM	Verastem, Inc. Common Stock	P - Purchase		96,260	2,029,593	4.98	10.00	962,600	20,295,930
2012-02-03	2012-02-01	4	VSTM	Verastem, Inc. Common Stock	C - Conversion		76,190	1,933,333	4.10
2012-02-03	2012-02-01	4	VSTM	Verastem, Inc. Common Stock	C - Conversion		714,286	1,857,143	62.50
2012-02-03	2012-02-01	4	VSTM	Verastem, Inc. Common Stock	C - Conversion		1,142,857	1,142,857

गैर-डेरिवेटिव या डेरिवेटिव प्रतिभूति की खुला बाज़ार या निजी खरीद

गैर-डेरिवेटिव या डेरिवेटिव प्रतिभूति का खुला बाज़ार या निजी बिक्री

कंपनी से प्रतिभूतियों का अनुदान, पुरस्कार या अन्य अधिग्रहण (जैसे एक ऑप्शन)

डेरिवेटिव का रूपांतरण

कंपनी को प्रतिभूतियों की बिक्री या हस्तांतरण

कंपनी से प्राप्त प्रतिभूतियों के हिस्से का उपयोग करके एक्सरसाइज मूल्य या कर दायित्व का भुगतान

इनसाइडर द्वारा या उसे प्रतिभूतियों का उपहार

इक्विटी स्वैप और समान हेजिंग लेनदेन

कंपनी से प्राप्त डेरिवेटिव प्रतिभूति के एक्सरसाइज या रूपांतरण (जैसे कि एक ऑप्शन)

किसी लेन-देन को स्वेच्छा से फॉर्म 4 पर रिपोर्ट किया गया

अन्य (लेन-देन का वर्णन करने वाले फ़ुटनोट के साथ)